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Abstract
A dramatic change in cell phenotype is sometimes seen in an advanced stage of 
mouse skin carcinogenesis when a relatively well-differentiated squamous cell 
carcinoma progresses to a less differentiated spindle cell carcinoma. This thesis 
describes a study of some genetic and epigenetic events that may be responsible for the 
squamous to spindle cell transition using a panel of fixed morphology and plastic 
morphology cell lines.
The experimental approaches used include genetic and cell biology-based studies. 
An allelotype of clonally related but morphologically distinct cell lines, A5, B9 and D3 
was compiled using 118 informative markers and genetic alterations distinguishing the 
differing cell types have been described. Alterations distinguishing the squamous and 
spindle cells were found on chromosomes 1, 4, 5, 6, 8, 12, 13, 16, 18 and 19. The most 
interesting of these with respect to tumorigenesis are on chromosomes 4 and 6; these 
have been shown to be involved in carcinogenesis in other studies. Although no 
specific allelic losses were shown to correlate with the squamous/spindle transition, this 
study has provided information on the lineage of clonally related cell lines from the 
same tumour and has provided some clues to the gross alterations that may be central to 
this process.
A wide range of biochemical studies have also been used to characterise the fixed 
morphology cell lines plus additional cell lines which have more plastic morphologies 
i.e. the SN161 single cell clones. It has been possible to induce the transition from a 
squamous morphology to a more fibroblast-like phenotype in vitro and in vivo and some 
of the candidate effectors of this change have been analysed.
When the SN161 cell lines are injected into nude mice, they all produce spindle 
tumours regardless of their morphology in vitro. Explants from tumours induced by 
squamous cell lines can regain their squamous morphology when grown in normal 
culture conditions. It seems that some factor present in vivo is encouraging the spindle
phenotype; alternatively some factor present in vitro could be encouraging the 
squamous phenotype.
Specific extracellular factors were shown to influence the morphology of SN161 
derived cell lines. Growth on fibronectin coated plates made the spindle cells more 
fibroblast-like but had no effect on the squamous cells. The same was true for Matrigel 
coated plates.
The most interesting result was found with TGFp treatment of the cells. This 
induced the squamous cell lines, E1N and E4, to become fibroblast-like and caused their 
E-cadherin to become delocalised and its expression reduced. This observation was 
consistent with the appearance of the spindle morphology. This system can now be 
used to study the immediate consequences of changes of morphology rather than 
secondary changes which can complicate results based on the study of spindle tumours.
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Chapter 1 
Introduction
1.1 Introduction
Age is widely recognised as an important risk factor in the development of cancer 
since a long latency period is characteristic of many types of neoplasia. The typical 
increase in susceptibility with age may be partly explained by a requirement to 
accumulate sufficient genetic alterations that allow the uncontrolled growth that causes 
neoplasia. The long-term aim of cancer research is to identify such genetic events and 
the biochemical changes that allow normal cells to proliferate abnormally and progress 
through various stages to malignancy. Some genetic alterations may be mediated 
through gross chromosomal changes and therefore may be cytogenetically detectable. 
The corollary is that characterisation of such chromosomal rearrangements should lead 
to the identification of genes involved in cancer.
However, mutational (genetic) events in cancer cells are not the only factors 
affecting cancer development. Environmental (epigenetic) factors also affect the 
evolution of malignancy e.g. changes in tissue biology with increasing age may provide 
an environment that contributes to tumour progression. Indeed, the pattern of metastasis 
in solid tumours is strongly influenced by the surrounding normal tissue environment, 
presumably reflecting the nature of interactions with the extracellular matrix and 
presence of local growth factors (Liotta, 1986). These are important non-genetic 
considerations. The involvement of both of these aspects of tumorigenesis i.e. genetic 
and epigenetic factors will be discussed.
1.2 Genetic alterations in carcinogenesis
The idea that carcinogenesis is a multistep process which starts with a single 
initiated cell that proceeds to form a neoplastic growth has been generally accepted for 
many years based on information from the epidemiology of human cancers and animal 
model systems. Much cancer research work is focused on the nature and consequences
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of the genetic alterations that lead to deregulation of cellular proliferation and 
differentiation control mechanisms.
During the progression of tumours, neoplastic cells are thought to accumulate 
increasing numbers of genetic alterations that are generated by random, somatic 
mutational events (Nowell, 1976) and it has been proposed that the more genetic 
changes tumours undergo, the more malignant they become (Vogelstein et al., 1989). 
Natural selection presumably favours the development of a progressively more 
malignant phenotype, aided by an increased rate of mutational events as the genetic 
instability of the tumour cell population increases.
Evidence to support this hypothesis comes from analyses of mouse skin 
malignancies which consist of aneuploid cells with genetic changes indicative of 
increasing genetic instability (Aldaz et al., 1987). Gross chromosomal abnormalities 
such as translocations and large deletions are frequently observed in various human 
cancers also, especially in tumours of progressed stages (Holliday, 1989). Some of 
these changes will simply be a consequence of genomic instability and will have no 
causal role in tumorigenesis. However, some presumably play a central role in tumour 
development. Some genetic losses may cause a change in cell morphology related to the 
loss of differentiation markers while others may confer malignant properties related to 
metastasis such as invasiveness and motility. The purpose of the work described here 
was to identify such changes and test their relevance to the altered phenotype of mouse 
epithelial cells in late stages of experimentally induced skin carcinogenesis.
Such phenotypic changes are often a result of mutations affecting two major 
classes of gene; the proto-oncogenes and tumour suppressor genes. Mutations that 
potentiate the functions of proto-oncogenes create oncogenes that promote the growth of 
tumour cells. Conversely, genetic lesions that inactivate tumour suppressor genes 
liberate cells from the normal growth constraints imposed by these genes, yielding 
unconstrained growth of cancer cells. The complexity and diversity of cellular 
pathways dictate that progression of most tumours to full malignancy requires both
2
types of change in the tumour cell genome. The mouse model used for this study is 
ideally suited to the examination of genetic alterations.
1.2.1 Oncogenes
The study of oncogenes began some time ago and now much is known about their 
causal role in carcinogenesis. Proto-oncogenes and their viral counterparts, first 
discovered as the transforming genes of retroviruses, have been established as frequent 
causes of the neoplastic transformation of mammalian cells (Bishop, 1981; Bishop and 
Varmus, 1982).
One of the most significant advances in cancer research was the discovery that the 
retroviral oncogenes had normal cellular counterparts - proto-oncogenes (Stehelin et al., 
1976; Bishop, 1981). In transformed cells, oncogenes encode proteins that function 
abnormally, inappropriately or at increased concentrations, resulting in escape from the 
normal growth controls that regulate cell division and differentiation. Therefore, 
mutations in proto-oncogenes that alter their function can cause transformation e.g. 
activation of the H-ras oncogene by an A-T transversion at codon 61 results in initiation 
of skin carcinogenesis in mice. Interestingly, there is a good correlation between the 
type of carcinogen used to initiate tumour formation and the particular activating 
mutation of H-ras (Quintanilla et al., 1986). Increased expression of the oncoprotein 
due to amplification or translocation can also be the cause of tumorigenesis e.g. as seen 
with c-myc (Garte, 1993).
Oncogenes can generally be divided into 4 groups according to the point where 
they interfere with cell growth control: growth factors (e.g. sis), growth factor receptors 
(e.g. erbB, fms, kit), cytoplasmic transducers of growth factor responses (e.g. src, ras, 
raf) and transcription factors that mediate growth factor-induced gene expression (e.g. 
jun, fos) i.e. they can be involved in the disruption of normal growth factor related 
signalling at any point on that pathway. These examples all lie at different positions on 
the same pathway but equivalents can be found on other, as yet independent, pathways.
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Due to these multiple levels of control, it is not surprising that a single oncogene is 
unable to cause transformation alone; complete transformation usually requires the 
cooperation of oncogenes from different categories (Hunter, 1991). This lends support 
to the multistage model of carcinogenesis (see section 1.4).
1.2.2 Tumour suppressor genes
The second category of genes central to studies of carcinogenesis, tumour 
suppressor (TS) genes was discovered more recently but has now been studied in great 
detail too. As would be expected, molecular analysis of TS genes is revealing that their 
products are involved in diverse cellular functions e.g. cell adhesion, signal transduction 
and cell cycle control. However, it is surprising that most of the TS gene products now 
known had not been previously identified in studies of normal cells; consequently their 
analysis is contributing not only to understanding of tumorigenesis but also basic cell 
biology. One of the aims of the work described here was to identify putative TS genes 
involved in a specific stage of mouse skin carcinogenesis with a view to learning more 
about genetic changes involved in the acquisition of a metastatic phenotype. Previous 
work had suggested that TS genes may be affected (Stoler et al., 1993).
The earliest evidence suggesting the existence of tumour suppressor genes came 
from cell fusion studies (Harris et al., 1969a). Hybrids between tumour cells and 
normal cells were no longer tumorigenic upon injection into animals and there seemed 
to be some kind of tumour suppressing signal present in the normal parent cell line since 
loss of specific chromosomes from the normal parent correlated with re-expression of 
tumorigenicity in hybrid cells (Harris and Klein 1969b).
Although these observations were first made 25 years ago, progress has since been 
slow because TS genes are, by definition, lost during carcinogenesis. This characteristic 
property underlies the experimental difficulties hindering their analysis and explains the 
10 year lag of this research behind that of oncogenes; it is more difficult to study a loss 
of function rather than a gain of function. A major breakthrough came from the method
4
by which the RB gene was detected. It has provided an important basis for the 
techniques that are now used to search for TS gene loci, including those presented in 
this thesis.
1.2.3 Retinoblastoma and mechanisms of loss of heterozygosity
Human genetics provided the first clues to the existence of TS genes. Studies of 
retinoblastoma, a childhood cancer of the retina, showed that it occurred both in 
sporadic and familial forms. A basic model of how TS gene loss led to tumour 
formation was first proposed by Knudson from a statistical analysis of retinoblastoma 
(Knudson, 1971). The incidences of unaffected carriers, unilateral and bilateral 
retinoblastoma led Knudson to propose a " two hit " model for development of the 
cancer. His hypothesis was that in the dominantly inherited form, the first mutation is 
passed through the germline while the second mutation occurs in the somatic cells. In 
the sporadic form, both mutations are somatic.
Several chromosomal mechanisms which could lead to the phenotypic expression 
of a recessive allele have been discussed (Cavenee et al., 1983). They are depicted in 
figure 1. The first copy of the TS gene is inactivated by somatic or germline mutation. 
The region carrying the surviving wild type allele may then be replaced by a duplicated 
copy of the homologous chromosomal region that has been mutated. This process 
causes a reduction to homozygosity at the RB locus i.e. a loss of heterozygosity (LOH). 
The mechanisms involved can be chromosomal non-disjunction, mitotic recombination 
or gene conversion. These steps that lead to homozygosity of a mutant suppressor allele 
usually involve flanking chromosomal regions as well and unrelated DNA markers 
mapping to nearby sites also become homozygous. Therefore, repeated observation of 
LOH of a specific chromosomal marker in cells from a particular tumour type suggests 
the presence of a closely mapping TS gene, the loss of which is involved in 
tumorigenesis.
5
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Using RFLP analysis, Cavenee et al (Cavenee et al., 1983), found evidence for 
non-disjunction and chromosome loss, non-disjunction and reduplication and mitotic 
recombination on chromosome 13 in retinoblastoma DNA when compared to normal 
DNA from the same patient. It was later shown that in hereditary cases of 
retinoblastoma, the copy of chromosome 13 which remained in the tumours was 
inherited from the afflicted parent and the chromosomal changes detected had 
uncovered a recessive mutation (Cavenee et al., 1985).
These reports resulted in a great leap forward in the understanding of cancer 
predisposition and soon more inherited cancer syndromes were being analysed in this 
way.
1.2.4 p53 mutation is a common event in tumours
The most intensively studied tumour suppressor , p53, was originally found 
as a complex with large T antigen and has subsequently been the subject of many LOH 
studies. Mutations of the p53 gene are the most common mutations found to date in 
tumours of widely ranging origins (Hollstein et al., 1991). In most cases, missense 
mutations occur accompanied by loss of the remaining wild-type allele, leading to 
complete loss of wild-type p53 expression.
This loss of expression through recessive genetic alterations is consistent with the 
categorisation of p53 as a tumour suppressor gene but the situation can become more 
complicated. Unlike many other genetic changes in tumours, mutations of the p53 gene 
do not always result in complete loss of protein function. Some mutants may act as 
dominant negatives which inactivate any remaining wild-type protein while others may 
have acquired their own DNA-binding properties which were not typical of the wild- 
type form (Vogelstein and Kinzler, 1992).
The normal functions of p53 have been the focus of a great deal of attention. The 
precise mechanism by which p53 inactivation contributes to tumorigenesis is still not 
clear but p53 is now known to be a regulator of apoptosis (reviewed in Oren, 1994). It
6
is a nuclear phosphoprotein which appears to play a role in cell cycle checkpoint 
control, inducing G1 arrest in reponse to DNA damage (Kuerbitz et al., 1992).
It has been proposed that p53 may serve as a "guardian of the genome" by 
preventing proliferation of cells that have sustained some form of genetic damage (Lane, 
1992). Cells lacking wild type p53 fail to arrest in G1 and the resulting genetic 
instability permits the accumulation of many genetic alterations which would normally 
not be allowed to persist. Although the consequences of these links have not been 
explained as yet, it is clear that p53 has a crucial role to play in normal cell processes 
and its link with tumorigenesis is undisputed.
Evidence for the importance of p53 mutations in tumorigenesis comes from the 
study of human tumours, animal tumour models and cell culture. The first evidence for 
germ-line mutations in p53 came from studies of 5 families with Li Fraumeni syndrome 
(Malkin et al., 1990) which showed that germline p53 mutations could be detected in all 
of the families tested. This work established a solid link between p53 mutations and 
susceptibility to Li-Fraumeni syndrome.
Further evidence for the importance of p53 at specific stages of tumour 
development has come from the mouse skin model. Loss of heterozygosity for markers 
on mouse chromosome 11 where the p53 gene is located and mutation of the p53 gene 
occurred in some carcinomas but not in papillomas in mouse skin carcinogenesis studies 
(Bums et al., 1991; Ruggeri et al., 1991).
A study of tumour development in p53 knockout mice also placed p53 mutations 
at a late stage. A comparison of the occurrence of p53 mutations in chemically-induced 
skin tumours in normal mice that have two wild-type alleles with that in genetically 
altered mice carrying either one or no p53 alleles showed that the papilloma yield was 
similar in wild-type and hemizygous mice but reduced in null mice (Kemp et al., 1993). 
Null mice developed a larger number of carcinomas instead. Most significantly, the rate 
of appearance of carcinomas in the hemizygous mice was associated with the loss of the 
remaining p53 allele. Loss of wild type p53 does not seem to increase the incidence or 
shorten the latency of appearance of papillomas. It does, however, enhance the rate of
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malignant progression as reflected by the dramatic increase in the rate of appearance of 
carcinomas. Furthermore, the majority of carcinomas from the hemizygous and null 
mice were undifferentiated squamous carcinomas in contrast to the carcinomas in the 
normal mice which were mainly well-differentiated tumours.
p53 has also been shown to contribute to many types of neoplasia including 
colorectal cancer (reviewed in Fearon and Vogelstein, 1990). p53 mutations typically 
occur in late stages of tumour progression; they are rarely observed in benign adenomas 
but are common in malignant carcinomas. Perhaps p53 mutation provides a selective 
advantage during tumour progression once other genetic alterations have taken place.
1.2.5 Other human tumour suppressor genes
The field of tumour suppressor genes has undergone rapid expansion in the past 
20 years and there are now tumour suppressor genes known to affect all major cellular 
processes.
After retinoblastoma, Wilms tumour was the second cancer which was shown to 
have hereditary and non-hereditary forms. In a similar way to the identification of the 
Rb gene, LOH and deletions at l lp l3  were the first clue to the site of the WT1 gene 
which has since been cloned (Call et al., 1990; Gessler et al., 1990). However, the 
genetics of this disease are more complicated than retinoblastoma and different loci 
seem to be associated with sporadic and inherited forms of this cancer (van Heyningen 
and Hastie, 1992).
The neurofibromatosis gene, NF1, and the familial adenomatous polyposis gene, 
APC, have similar patterns of inheritance and allele loss associated with tumours. The 
NF1 gene codes for a GTPase activating protein that regulates the activity of ras. It has 
been mapped to chromosome 17qll and cloned (Xu et al., 1990). It will be discussed in 
more detail in section 1.5.2.
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Mutations of the APC (Adenomatous Polyposis Coli) gene appear to cause 
sporadic and familial forms of colorectal cancer. In fact, such mutations seem to be the 
initiating event for the development of colon cancer.
The APC protein associates with a  and |3 catenin which are thought to link the E- 
cadherin/catenin complex to the cytoskeleton (Su et al., 1993; Rubinfeld et al., 1993). 
Therefore, APC may be involved in cell adhesion through its association with catenins. 
If this is true, mutations in the APC gene may result in production of mutated protein 
unable to interact with catenins and hence in a loss of APC-catenin-cadherin complex 
formation. Consequently, a loss of cell-cell interaction could lead to a lack of contact 
growth inhibition, resulting in hyperplasia. The subject of altered cell-cell and cell- 
matrix adhesion will be discussed further in section 1.6 with respect to tumour invasion 
and metastasis.
Germline mutations of the APC gene which has been mapped to chromosome 
5q21 and cloned, predispose individuals to familial adenomatous polyposis (FAP), a 
major cancer of adults (Groden et al., 1991; Nihisho et al., 1991). FAP begins with the 
formation of numerous benign polyps in the colonic mucosa, all of which have APC 
mutations. In addition to these alterations, progression to malignancy requires further 
mutations in the K-ras oncogene, p53 and the DCC TS gene.
The DCC (Deleted in Colorectal Carcinoma) gene was isolated as a result of its 
location on chromosome 18 which showed loss of heterozygosity in human colorectal 
cancer (Fearon et al., 1990). It encodes a protein with a high degree of homology to N- 
CAM, a cell adhesion molecule of neural cells, and other cell surface glycoproteins. 
DCC expression is most commonly lost in late adenomas as they progress to an invasive 
phenotype. Loss of cell adhesion molecules is a common feature of invasive and 
metastatic tumours and will be discussed in more detail in section 1.6.5.
Other candiate TS genes have been identified by a variety of means. These 
include MCC (Mutated in Colorectal Cancer) (Kinzler et al., 1991), PTPy, a protein 
tyrosine phosphatase (LaForgia et al., 1991), nm23, a nucleoside diphosphate kinase 
(Steeg et al., 1991) and K-rev 1, a GTP-binding protein (Kitayama et al., 1989). In most
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cases, the evidence for their being TS genes centres on their loss or inactivation during 
tumour development, although more formal proof comes from a specific tumour 
suppressing effect when the wild type form of the gene is reintroduced into tumour 
cells. K-revl was identified as a result of its ability to revert K-ras transformed cells to 
a less transformed phenotype (see section 1.5.4).
New putative TS genes are rapidly being described as technical hurdles are being 
overcome. The most productive approach to date has come from a combination of 
recent advances in genetics and molecular biology i.e. the analysis of microsatellite 
markers by the polymerase chain rection (PCR).
1,3 Microsatellites as genetic markers
The use of PCR-analysed microsatellite markers as a method for chromosomal 
mapping in the mouse has rapidly become well established. This technique has been 
adapted and used in the search for TS gene loci, revolutionising this research field. It is 
the method which was used to analyse the genetic alterations in mouse skin tumours 
described in this thesis.
Microsatellites are simple dinucleotide repeats, usually 15-40 copies of (CA) or 
(GA), which are within the size range of Taq polymerase and can therefore be amplified 
by PCR using oligonucleotide primers complementary to unique DNA sequences 
flanking the microsatellite (figure 2). They are ideally suited to the search for TS gene 
loci because they are highly polymorphic and occur frequently in mammalian genomes 
so they can be used to screen tumour cell genomes and identify regions of LOH. They 
are inherited in Mendelian fashion in the same way as RFLPs but this approach has 
several advantages over the more traditional method of RFLP analysis which detected 
DNA polymorphisms at restriction enzyme sites. These, by their nature, are rare and 
their detection can require the use of 20-30 different enzymes followed by blotting and 
hybridisation protocols which are time-consuming. Microsatellites, in contrast, are
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highly polymorphic and can be easily analysed by agarose and polyacrylamide gel 
electrophoresis. Most importantly, they are very common - it has been estimated that 
there are at least 5x10^ sequences that contain (CA)n repeats in the mouse and human 
genomes (Hamada et al., 1982; Weber and May, 1989) so there are potentially enough 
microsatellites within the mouse genome to have a marker every lcM.
1.3.1 LOH as means of locating TS genes
The hallmark of TS genes is that they are deleted, or suffer LOH, at high 
frequency in certain tumour types. These deletions often involve gross genetic 
alterations which can be detected by screening with polymorphic markers. LOH 
analysis has been widely used both alone and in conjunction with other techniques such 
as cell fusion and micro-cell mediated chromosome transfer to look for candidate TS 
genes. These approaches have succeeded in identifying common regions of LOH in 
most types of human cancer (Lasko et al., 1991).
Reproducible LOH at a particular locus is a good indicator of the likely presence 
of a TS gene in this region, as discussed with respect to RB (section 1.2.3). A summary 
of the main regions of LOH in a wide range of human tumours is given in table 1. Most 
studies have been analyses of human tumours, but there is also good data emerging from 
animal model systems. Syntenic regions between mouse and human chromosomes have 
been defined (Copeland et al., 1993) and it is interesting that the same regions are 
frequently included in the lists of LOH.
For example, the human 9p21 region contains chromosomal alterations in glioma 
cell lines, non-small cell lung cancer lines, leukaemia lines and melanoma lines. Certain 
9p21 markers are deleted in more than half of all melanomas (Isshiki et al., 1994) and 
LOH affecting chromosome 9 has been seen in 86% of DNAs from melanoma patients 
(Fountain et al., 1992). The MTS1 (multiple tumour suppressor) gene maps to 9p21 and 
there is some evidence that it is a familial melanoma gene (Hussussian, 1994). It 
encodes p i6, a cell cycle-related gene, which may have a role in controlling cell
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C H R O M O S O M E T U M O U R  T Y P E
1 lung, liver, stom ach
2 lung
3 lung, kidney, bladder, breast, head & neck, cervical
4 liver, ovarian
5 lung, liver, stomach, colorectal, kidney, ovarian, cervical
6 breast, ovarian
7 breast
8 lung, liver, colorectal, prostate, breast
9 lung, bladder, breast
1 0 kidney
11 parathyroid, lung, liver, colorectal, kidney, bladder, 
breast, prostate, ovarian, cervical
13 lung, liver, stom ach, kidney, ovarian
1 4 liver
1 6 liver, breast, prostate
1 7 lung, liver, stomach, colorectal, bladder, breast, ovarian
1 8 lung, stomach, colorectal, kidney, breast, prostate, ovarian
1 9 lung
2 2 liver, colorectal, breast, ovarian
X ovarian
TABLE 1: LOH in human epithelial tumours 
(summary of published data)
proliferation. Human chromosome 9p21, where pl6 is localised, is syntenic with part of 
mouse chromosome 4. This region is altered in mouse tumours (Kemp et al., 1993|a).
Other areas of research also point to the importance of a gene on chromosome 9. 
LOH at 9q31 is frequently seen in Gorlin syndrome which predisposes individuals to 
basal cell carcinoma of the skin plus other types of tumour and developmental defects 
(Gailani et al., 1992). This implies that the gene involved is inactivated in 
tumorigenesis and may therefore be classed as a tumour suppressor gene. The gene for 
Ferguson-Smith syndrome, which causes multiple epidermal tumours, (Goudie et al., 
1993) also maps to the same location, suggesting that perhaps both syndromes are 
caused by mutation of the same gene.
Contamination of primary tumours with normal tissue tends to reduce the 
sensitivity of LOH analysis, resulting in underscoring of LOH frequency but this is not 
a problem when working with cell lines isolated from tumour biopsies. These originate 
solely from tumour cells which are much more readily immortalised in culture 
compared to their normal counterparts.
One important advantage of LOH analysis over traditional techniques such as 
cytogenetics is that certain chromosomal mechanisms for allele loss can be 
distinguished e.g. mitotic recombination. The first demonstration of mitotic 
recombination and non-disjunction events in mouse tumours focused on chromosome 7 
(Bremner and Balmain, 1990). This study showed that allelic imbalance on 
chromosome 7 was a very common event in mouse skin tumours which had been 
initiated by mutational activation of H-ras. H-ras itself may be the main factor involved 
in tumorigenesis in this case but other alterations are also required at each stage of 
tumour development.
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1.4 Multistep carcinogenesis
The multistep model of carcinogenesis was first proposed by Foulds in 1954 
(Foulds, 1954) and since then it has been possible to identify specific genetic alterations 
that correlate with defined stages in several human tumour types including malignant 
melanoma (Balaban et al., 1986; Williams et al., 1993), glioma (James et al., 1988) 
small-cell lung carcinoma (Naylor et al., 1987) and colon cancer (Vogelstein et al., 
1988). Hereditary conditions such as retinoblastoma provided the first evidence for TS 
gene involvement in tumorigenesis and are useful for the study of mechanisms involved 
in tumour development where a single locus plays a central role in the process. 
However, it is more common for the tumour to be caused by a number of contributory 
factors.
Colon cancer offers the best clinical illustration of multiple somatic mutations 
underlying multistage carcinogenesis and genetic changes from the earliest to the most 
advanced stages have been studied in detail (reviewed in Fearon and Vogelstein, 1990 
and Stanbridge, 1990). It is now apparent that an accumulation of mutations in several 
genes correlates with progression via epithelial dysplasia, adenoma and carcinoma in 
situ to complete malignancy. Furthermore, an association has been found between the 
number of allelic losses at multiple chromosomal sites and a poor prognosis.
The same is true for tumours induced in experimental animals and rodent models 
have been particularly informative.
1.4.1 Mouse skin structure
One of the most commonly used models is the mouse skin system. In a stratified 
epithelium, such as epidermis, keratinocytes in the basal layer adhere to the basement 
membrane and adjacent cells on either side and above. This layer is where proliferation 
takes place and epidermal cells are renewed. About 60% of the cells remain here and 
will divide again; the other 40% are programmed to differentiate and are pushed out into
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the granular layer (Fuchs and Byrne, 1994). These suprabasal cells have lost adhesion 
to the matrix and instead adhere to similar cells on all sides. They have lost 
proliferative ability also and begin to express markers of differentiation such as keratins 
1 and 10. In the granular layer proteins are cross-linked to form the insoluble comified 
envelope and the cells enlarge and flatten out. Finally, at the comified layer, the nucleus 
begins to disintegrate, the cells die and become squames and are eventually brushed off. 
Therefore, the various stages of in vivo keratinocyte differentiation and proliferation 
take place in well-defined compartments. In carcinogenesis this regulation is disrupted.
1.4.2 Mouse skin model system
Work with animal models, particularly the mouse skin, has demonstrated that 
initiation, which is irreversible and involves chemical carcinogen interaction with DNA, 
is a somatic event that may occur in a single target cell. In contrast, promotion, the 
clonal expansion of initiated cells to a benign lesion such as a papilloma, has been 
associated mainly with epigenetic factors activated by phorbol esters used in 
experimental tumour induction (Furstenberger et al., 1981; Hecker et al., 1982).
The next stage, progression, is the transition from a benign premalignant lesion to 
a malignant tumour. It has most commonly been studied using human tumours. 
Clinically, this stage poses most problems. Phenotypic alterations typical of progression 
include drug resistance, angiogenesis, invasiveness and metastasis which are usually the 
reasons for failure of treatment of human cancer and cause of death. Many of these new 
properties may be due to the acquisition of new mutations but epigenetic factors are 
important also.
The development of skin tumours in mice can easily be followed. Individual 
tumours can be measured and signs of malignant change in benign tumours can be seen 
with the naked eye. Gross pathological changes such as ulceration and hyperkeratosis 
can also be detected. After a single application of an initiator and multiple applications 
of a promoter, numerous benign papillomas arise in the back of the treated mouse; about
14
5-10% of these then progress towards malignancy. These carcinomas may be squamous 
cell carcinomas which still retain many of the differentiation features of the original 
tissue e.g. E-cadherin and keratin expression or they may be a more advanced stage 
spindle cell carcinoma which has lost these epithelial markers and consists of fusiform 
cells instead (figure 3).
Animal models have been used for the detection and characterisation of mutations 
in positive effector genes. Data from the mouse skin model have strongly suggested 
that genetic events have a causative role in tumour progression e.g. non-genotoxic 
tumour promoters such as TPA do not enhance the conversion of mouse skin papillomas 
to carcinomas whereas mutagenic or genotoxic carcinogens such as MNNG do 
(Margison and O'Connor, 1978). Chromosomal aberrations involving gross alterations 
of DNA sequences such as deletion, amplification and translocation are frequently 
observed in mouse skin carcinogenesis (Conti et al., 1986; Aldaz et al., 1989) and 
several stage-specific genetic alterations have already been identified in mouse skin 
tumours (summarised in figure 4).
The main advantage of the mouse skin system is that the tumour aetiology can be 
controlled and cell lines can be obtained at sequential stages of tumour development; 
these explants retain many of the characteristics of the original tumour. However, from 
the point of view of TS gene analysis, the most useful aspect is the availability of inbred 
mouse strains which can be cross-bred to give highly polymorphic F\ hybrids with a 
high degree of heterozygosity. Such mice have proved to be invaluable in the analysis 
of genetic alterations in skin tumours.
1.5 The ras superfamilv and tumorigenesis
Ras mutations and perturbations of the signalling pathways it is involved in are 
common alterations in tumours. Ras proteins are components of receptor-mediated 
signalling pathways controlling cell proliferation and differentiation. This means that
15
S Q U A M O U S  C A R C IN O M A
S P IN D L E  C A R C IN O M A
Figure 3: Typical histology of a squam ous and a spindle 
carcinom a, (micrographs courtesy of A. Balmain)
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activated forms of various components of the ras pathway can contribute to cancer by 
bypassing the regulation of cell growth by growth factors. Ras itself is a common target 
for mutation; more than 30% of all human carcinomas have mutant ras (reviewed in 
Bos, 1989).
1.5.1 Ras mutations and mouse skin tumorigenesis
Genetic changes affecting H-ras have been reported in the mouse skin model 
system (Quintanilla et al., 1986; Bremner and Balmain, 1990). Activation of H-ras is an 
early event. Indeed, a correlation between the type of carcinogen used to initiate tumour 
formation and the particular activating mutation of H-ras has been demonstrated 
(Bremner and Balmain, 1990). Although ras gene mutations are probably an important 
initiating event, they are insufficient for the formation of benign papillomas. These only 
appear after treatment with a tumour promoter such as TPA which allows the clonal 
selection of rare initated cells that are surrounded by normal cells. Subsequent genetic 
alterations accumulate over time and may encourage the malignant conversion of benign 
papillomas.
Amplified mutant ras has been shown to be associated with spindle cell 
carcinomas (R. Crombie, PhD thesis, 1994). The mutant ras content of squamous 
tumour cells increases as they become less differentiated and this increase may 
encourage the switch to a spindle carcinoma but the complete transition requires the 
alteration of another locus. Experiments in which the ratio of mutant to normal ras in 
squamous and spindle cells was altered showed that when the mutant ras allele is lost 
from spindle cells, only their tumorigenicity and not their morphology is affected (R. 
Crombie, PhD thesis, 1994).
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1.5.2 NF1 and p120GAP are ras effector molecules
The products of the mammalian ras proto-oncogenes, Harvey-ras (H-ras), Kirsten- 
ras (K-ras) and N-ras are members of a family that includes at least 40 ras-related small 
GTP-binding proteins (reviewed in Barbacid, 1987) which share the ability to 
interconvert between an inactive (GDP-bound) and an active (GTP-bound) state 
(Bourne et al., 1990). The ratio of GTP to GDP on ras can be regulated by either 
altering the rate of GTP hydrolysis or by altering the rate of nucleotide exchange. 
Although ras proteins possess intrinsic GTPase and nucleotide exchange functions, 
several proteins exist that can stimulate GTPase activity (GTPase activating proteins, 
GAPs) and stimulate exchange (guanine nucleotide dissociation stimulators, GDSs), 
acting synergistically to control ras activity. The NF1 and GAP proteins both stimulate 
the GTPase activity of ras.
Deletion or abnormal function of NF1 can contribute to tumours of the central 
nervous system, indicating that normal NF1 can act as a tumour suppressor (Li et al., 
1992; Basu et al., 1992). NF1 defects have also been implicated in other types of 
sporadic cancer e.g. neuroblastomas (Seizinger, 1993) and melanomas (Andersen et al., 
1993) but the action of abnormal NF1 in these tumours is not understood.
The NF1 protein has a high degree of homology with the C-terminal portion of 
pl20GAP and both proteins regulate ras by altering the ratio of rasGDP to rasGTP. In 
addition to their roles as negative regulators of ras, both GAPs seem to possess a second 
role as downstream effectors of ras activity (reviewed in McCormick, 1990). NF1 binds 
ras with a much higher affinity than GAP, indicating that it could be a more significant 
regulator of ras than GAP, considering the concentration of ras in the cell (Bollag and 
McCormick, 1991). Indeed, the reduced levels of functional NF1 in Schwannomas 
result in an elevation of GTP-bound ras although the expression of GAP is normal (Basu 
et al., 1992; DeClue et al., 1992). However, NF1 is not universally expressed so its 
effector function may be more important in some cells than others. Whether NF1 acts
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as a negative regulator or downstream effector of ras may depend on the cell type or 
stage in development.
The effector function of pl20GAP has been localised to the N-terminal domain 
which binds to receptor and non-receptor tyrosine kinases e.g. the EGF receptor, PDGF 
receptor and src (Ellis et al., 1990). Binding of rasGTP to the catalytic domain of 
pl20GAP may cause a conformational change that exposes the N-terminal SH2/SH3 
effector domains, thereby permitting their interaction with downstream targets and 
relaying the ras signal to transcription factors in the nucleus.
Such downstream targets may include two tyrosine phosphorylated proteins, p62 
and p i90, which have been shown to bind the N-terminal domain of GAP through its 
SH2 domains (Wong et al., 1992; Settleman et al., 1992). In cells stimulated with EGF 
or transformed by v-src, GAP forms complexes with p62 and pl90 (Ellis et al., 1990; 
Moran et al., 1991).
pl90 contains at least two distinct functional domains; an N-terminal GTPase 
domain and a C-terminal RhoGAP domain. It is a specific GAP for the rho family, 
therefore interaction between rasGAP and p i90 may coordinate the ras and rho 
signalling pathways (Hall, 1992).
The second pl20GAP associated protein, p62, has significant homology to a 
hnRNP protein and binds RNA (Wong et al., 1992) therefore it may have a role in RNA 
processing. However, where this fits in with pl20GAP and ras signalling is still not 
clear since it now seems that binding of GAP to p62 and p i90 is independent of ras 
signalling (Pronk et al., 1993).
p62 may be closely related to p68, another RNA-binding protein. p68 also binds 
to src and becomes tyrosine phosphorylated during mitosis in normal and src- 
transformed cells (Taylor and Shalloway, 1994; Fumagalli et al., 1994). It has been 
suggested that p62 and p68 may both coordinate RNA stability; p62 by regulating 
cytoskeletal components and p68 by regulating nuclear components. A link between 
expression levels of these proteins and cell morphology was investigated in this study.
18
1.5.3 Ras-related proteins as tumour suppressors
Activated rasGTP activates a kinase cascade including raf, MAPKK (mitogen- 
activated protein kinase kinase) and MAPK (MAP kinase) leading to phosphorylation of 
transcription factors such as the jun proto-oncogene (reviewed in Roberts, 1992). The 
entire signalling pathway is conserved in the nematode and Drosophila and its most 
important elements are found in yeast so it seems to have a central role to play in 
signalling in eucaryotes.
To date, two mammalian GAPs for ras have been identified; pl20GAP which 
stimulates the GTPase activity of ras proteins by at least 10,000 times (Trahey and 
McCormick, 1987) and NF1, the gene product of the NF1 tumour suppressor gene, 
which also increases the rate of GTP hydrolysis. Oncogenic ras mutants have a reduced 
GTPase activity which is no longer stimulated by these GTPase activating proteins. 
Consequently, mutants are trapped in the active GTP-bound state and no longer require 
ligand-induced activation. Downstream signalling leading to the activation of 
transcription factors is therefore continuously stimulated. While mutations in ras 
proteins can deregulate their GDP/GTP cycling and lead to constitutive activation of ras 
function, the inactivation of ras GTPase activators or permanent activation of rasGDP 
dissociation stimulators may also indirectly lead to constitutive activation of ras. 
Therefore, GAPs may be putative TS genes while GDSs may be putative oncogenes. 
Evidence for these possibilities comes from the observation that loss of NF1 function in 
some human tumours results in elevated rasGTP levels (Basu et al., 1992; DeClue et al.,
1992) and overexpression of pl20GAP in NIH3T3 cells can suppress transformation by 
normal H-ras, (Zhang et al., 1990a). It can also reduce the level of rasGTP in 
unstimulated and PDGF-stimulated cells (Gibbs et al., 1990). However no losses of 
pl20GAP have been identified in tumours.
Molecules which bind rasGTP tightly but do not permit signalling are also 
candidate TS genes. One such protein is K-rev.
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1.5.4 K-rev1 is a ras antagonist
The K-rev 1 gene was isolated by its ability to produce morphologically 
untransformed revertants when transfected into Kirsten sarcoma virus-transformed NIH 
3T3 cells. In order to identify new genes affecting the ras signalling pathway, human 
cDNA libraries were transfected into ras-transformed fibroblasts and cDNAs able to 
alter the morphology of these cells were isolated (Kitayama et al., 1989). Further 
analysis of one clone, K-rev 1, revealed that its product is identical to rapl, a member of 
the ras superfamily of GTP-binding proteins (Pizon et al., 1988). K-rev 1 induced 
morphological and biological changes in transfected cells i.e. partial reversion of the 
malignant phenotype. Its overexpression can revert ras-transformed cells (Zhang et al., 
1990b) and can inhibit ras-stimulated gene expression in transient transfections (Sakoda 
et al., 1992) but the method by which K-rev 1 interferes with ras function is not yet clear.
1.6 Epithelial-mesenchymal transitions and invasion are linked
As described earlier, the specific stage of mouse skin carcinogenesis being studied 
was the advanced stage of tumorigenesis when squamous cell carcinomas progress to 
become spindle cell carcinomas. This change in phenotype has similarities to 
alterations seen during tissue development and can be influenced by extracellular factors 
as well as intracellular signalling via ras-related pathways.
1.6.1 Squamous v spindle carcinoma
In human carcinogenesis, spindle cell carcinomas tend to be recurrent or 
metastatic tumours and invasion and metastasis of these tumours are major causes of 
therapeutic failure. The transformed epithelial cells grow in an uncontrolled fashion and 
break through the basement membrane then invade the underlying mesenchyme. They
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can then settle at distant sites and form secondary tumours. Spindle cell carcinomas are 
relatively rare but analysis of the mechanisms by which they lose almost all of the 
differentiation markers of the original cell may provide information regarding the 
control of epithelial differentiation processes, in addition to providing insights into the 
process of metastasis.
Morphological and functional characteristics of metastasis were recognised years 
ago and the state of differentiation and degree of invasiveness of a tumour are known to 
determine cancer prognosis. However, although the epithelial origin of spindle cell 
carcinomas is well-documented, many questions regarding their development remain to 
be answered and the underlying molecular basis is only now being investigated.
Epithelial cell tumours i.e. carcinomas, account for 90% of human malignancies. 
Within this category of tumour there are two distinct types with important phenotypic 
differences; squamous and spindle carcinomas. Well-differentiated squamous 
carcinomas retain epithelial tissue structures, have well-developed intercellular 
junctions and are usually weakly invasive but they can become more invasive and 
metastatic and produce secondary tumours which are also squamous. This process may 
be facilitated by the involvement of spindle intermediates which appear transiently and 
act as a migratory form of the squamous carcinoma cells. A more stable epithelial 
organisation may be recovered once these cells have reached another site where 
conditions suit this type of growth. True spindle carcinomas, in contrast, are always 
poorly-differentiated and have an amorphous tissue structure, few cell-cell junctions and 
are more invasive. They have lost so many of the typical epithelial markers that their 
histology can sometimes be misleading and they may be mistaken for fibrosarcomas, 
but in situ they are still identifiable as carcinomas and some evidence of their epithelial 
origin can still be detected. They have been described in numerous organs in humans 
e.g. lung (Matsui and Kitagawa, 1991) breast (Kaufman et al., 1983) cervix (Steeper et 
al., 1983; Evans and Smith, 1980) and are also seen in experimentally induced skin 
neoplasia (Klein-Szanto et al., 1989).
21
One interesting marker that helps to differentiate squamous and spindle 
carcinomas is the type of intermediate filament protein they express. Studies of tumours 
induced in mice have demonstrated changes in the cytokeratin differentiation markers 
associated with neoplasia in general (Klein-Szanto et al., 1983; Roop et al., 1988). 
Cytokeratins 8 and 18 are the pair of keratins associated with simple epithelia and early 
stages of embryogenesis. They are not normally found in adult epidermis but have been 
shown to be expressed in human skin carcinomas, mouse tumours and in mouse 
keratinocytes transfected with oncogenic H-ras (Diaz-Guerra et al., 1992). Papillomas 
express keratins characteristic of basal cells (K5 and K14), suprabasal cells (K1 and 
K10) and hyperproliferative skin (K6 and K16) and squamous carcinomas show a 
dramatic reduction in expression of K1 and K10 but not the other keratins (Knapp et al., 
1987).
Studies by this group have shown a similar loss of intermediate filament 
differentiation markers in a number of mouse spindle cell lines (Stoler et al., 1993). In 
fact, spindle carcinomas usually express vimentin which is more typical of fibroblasts 
than epithelia. Vimentin expression provides a marker for the spindle cell phenotype 
but this altered intermediate filament switch alone does not give rise to the spindle 
phenotype (Sommers et al., 1992). These results are consistent with the altered 
differentiation state of malignant tumours. Many of these differences in cytoskeletal 
structure echo changes that occur during the initial formation of tissues and organs in 
the embryo.
1.6.2 Epithelial-mesenchymal transitions
The first tissues to emerge in the early vertebrate embryo are epithelial in nature 
and the mesenchymal cells of the body all derive from these embryonic epithelia in an 
epithelial-mesenchymal transition (EMT). Both tissue types are found in nearly every 
organ where they cooperate and support each others growth.
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The two cell types are very different phenotypically. Epithelial cells are closely 
associated with their neighbours by forming tight intercellular junctions and are thus 
immobile. Mesenchymal cells are, in contrast, only loosely associated and are therefore 
more mobile. During organ development, transitions from epithelia to mesenchyme 
occur and vice versa e.g. in neural crest development, neural crest cells change from an 
epithelial to mesenchymal phenotype (Thiery et al., 1982) and during kidney 
development, mesenchymal cells shift to an epithelial phenotype, (Vestweber et al., 
1985; Ekblom, 1989). This plasticity of cell phenotype is also evident in tumour 
development. As described in section 1.6.1, carcinomas can exist in squamous or 
spindle forms. These are reminiscent of epithelial and mesenchymal tissues 
respectively.
With a view to elucidating the factors controlling this switch in normal tissues and 
in disease states, numerous experimental approaches have been used to induce or revert 
the epithelial-mesenchymal transition. The conversion of epithelial cells into cells 
expressing mesenchymal properties can be studied in vitro e.g. in lens epithelium 
(Greenburg and Hay, 1986), in Madin-Darby canine kidney cells (Zuk et al., 1989) and 
in certain carcinoma cell lines (Boyer et al., 1989). Thus, many modulators of the 
epithelial phenotype have been identified. These include motility and growth factors 
that activate receptor tyrosine kinases; scatter factor (SF), acidic fibroblast growth factor 
(aFGF), epidermal growth factor (EGF) and transforming growth factor alpha (TGFa) 
can all convert epithelial cells to a fibroblastoid phenotype (Barrandon and Green, 1987; 
Stoker et al., 1987). Even simple treatments such as growing certain cell lines in low 
calcium conditions can change their morphology (Hennings et al., 1980).
Extracellular matrix molecules e.g. syndecan and laminin also affect cell-cell 
adhesion and differentiation, as do some epithelial junction complex proteins. 
Oncogenes may also be involved; transfection of cells with oncogenes such as ras 
(Garcia et al., 1986), expression of an inducible c-fos construct (Reichmann et al., 1992) 
or a temperature sensitive v-src protein (Behrens et al., 1993; Hamaguchi et al., 1993)
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can convert epithelial into mesenchymal cells which now have an altered differentiation 
program and express fibroblast proteins.
1.6.3 Control of epithelial morphology and motility
Epithelial morphogenesis is almost certainly controlled by a gene which is lost or 
inactivated in spindle cells rather than one which is activated or amplified. Evidence 
supporting this hypothesis has come from cell fusion studies which showed that the 
morphology of hybrids between spindle cells and epithelial cells was very similar to that 
of the epithelial parent (Stoler et al., 1993). Identification of the gene controlling 
epithelial differentiation characteristics is of great importance to carcinogenesis and 
development studies.
Changes in differentiation programs are typical of tumour cells but they are also 
necessary for various normal cellular processes. An essential requirement for tissue 
morphogenesis and remodelling is changes in cell adhesion molecules. Cells of any 
particular type possess a set of adhesive properties that may be both spatially and 
temporally regulated. A considerable amount is now known about the molecular 
mechanisms that mediate these properties both in normal tissue and in carcinogenesis.
1.6.4 Invasion and metastasis
Clinically, histological criteria of malignancy are cellular polymorphism i.e. 
variation in size, shape and staining pattern of cells and nuclei, a high proportion of 
mitotic cells, invasive growth and metastasis. Invasion is a hallmark of malignancy and 
a prerequisite for metastasis. In 1986, Liotta put forward a 3 step theory of invasion: 
locomotion, adhesion to basement membrane and dissolution of basement membrane 
(Liotta, 1986).
Defective cell adhesion is a common feature of tumours and is thought to play a 
part in the invasive and metastatic behaviour of neoplastic cells. Invasive cells break
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through the basement membrane and invade the underlying mesenchyme, spread into 
the tissues surrounding the primary tumour, enter blood vessels, lymphatics or body 
cavities and become dispersed to distant sites. Some may become trapped at new sites, 
extravasate and form new secondary tumours. This is a complex series of events that 
may involve various altered cellular properties such as secretion of proteolytic enzymes, 
alterations in cell motility, growth properties and adhesiveness; even before invading 
other tissues, the metastasising cells must loosen their contact with neighbours and pass 
through the basement membrane barrier.
Various oncogenes have been implicated in invasion and metastasis processes (Ki­
ras and HER2/neu) and various TS genes have been shown to be deleted or mutated at 
different stages of carcinogenesis including the benign/malignant transition e.g. RB, 
WT, p53 and DCC. The existence of specific metastasis suppressor genes has even 
been suggested by analyses with cell fusion and microcell-mediated chromosome 
transfer experiments (Ramshaw et al., 1983; Ichikawa et al., 1991; Ichikawa et al., 
1992b; Ichikawa et al., 1992a). Metastatic potential is suppressed when metastatic cells 
are fused with various non-metastatic cells or receive exogenously introduced 
chromosomes, suggesting that the loss of genetic information is a recessive trait.
1.6.5 Cell adhesion molecules as tumour suppressors
Likely candidates for the role of metastasis suppressors are cell adhesion proteins. 
In contrast to normal, highly organised epithelial tissues, carcinomas show reduced 
differentiation and a loss of normal tissue structure, partly due to impaired adhesion to 
their environment. In extreme cases, i.e. malignant tumours, there is invasion into 
surrounding normal tissues. In vitro properties of some transformed cells such as loss of 
contact inhibition and the ability to grow in soft agar suggest that tumour cells have lost 
the ability to respond normally to growth-regulatory signals induced by cell-cell and 
cell-extracellular matrix interactions. Cellular processes that control these 
characteristics can be influenced by soluble extracellular factors e.g. hormones and
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growth factors or structural interactions between neighbouring cells or between cells 
and the extracellular matrix.
Cell-cell and cell-matrix interactions involve cell surface adhesion molecules i.e. 
integrins, cadherins, members of the immunoglobulin superfamily and selectins. These 
molecules, in addition to providing physical contacts, may act as receptors that 
transduce extracellular signals and influence tumorigenesis via growth, differentiation 
and invasion pathways. Therefore, they could be classed as potential tumour suppressor 
genes. Indeed, the DCC protein that is deleted in colorectal cancer is thought to be a N- 
CAM-like cell adhesion molecule (Fearon et al., 1990) and the fa t gene implicated in 
imaginal disc hyperplasia in Drosophila is a cadherin-like molecule (Mahoney et al., 
1991).
1.6.6 E-cadherin as an invasion suppressor
In most tissues a major contribution to cell-cell adhesion is made by calcium- 
dependent cell adhesion molecules, the cadherins. E-cadherin is found exclusively in 
epithelial cells and is lost during the transition to the mesenchymal phenotype e.g. 
during early development when mesoderm separates from ectoderm (Takeichi, 1988).
A number of reports have discussed the correlation of loss of E-cadherin 
expression and acquisition of a fibroblastoid morphology and invasive properties in 
epithelial tumour cells (Behrens et al., 1989; Chen and Obrink, 1991; Frixen et al.,
1991). In a series of human tumour cell lines, invasion into collagen gels was inversely 
related to expression of E-cadherin and invasion was inhibited by transfection with a 
vector expressing E-cadherin (Frixen et al., 1991). The same was true for dog kidney or 
mouse mammary cells (Vleminckx et al., 1991). This suggests a possible "invasion 
suppressor" function for this cell adhesion molecule which may be a master molecule in 
the organisation of epithelial junction complexes.
Consistent with this hypothesis are the numerous observations of a correlation 
between loss of epithelial differentiation and gain of invasiveness with absent or non­
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functional E-cadherin protein. However, in some dedifferentiated tumours, E-cadherin 
expression was apparently normal, despite reduced intercellular adhesiveness 
(Shimoyama and Hirohashi, 1991). The permanent loss of E-cadherin expression is not 
essential for malignancy and metastasis since tumour cells present in various 
carcinomas and their metastases, or in metastasis-derived cell cultures are found to re­
express E-cadherin. Instead, the transient down-regulation, rather than irreversible loss 
of E-cadherin function, is thought to be a major factor contributing to the malignancy of 
carcinomas.
E-cadherin function may be abolished by biochemical modifications. The most 
likely explanation is that E-cadherin itself or one of the junctional complex proteins, 
perhaps one of the catenins, is phosphorylated and is therefore rendered non-functional. 
The reversibility of phosphorylation means that the proper structures could reform in 
metastases under different growth conditions. Some immunohistochemical studies of 
carcinomas have shown that although they express E-cadherin, the protein is not found 
in the correct location i.e. at regions of plasma membrane touching adjacent cells 
(Umbas et al., 1992). Transformation of chick embryo fibroblasts has provided 
evidence to support this hypothesis (Hamaguchi et al., 1993). It was shown that Rous 
sarcoma virus suppressed N-cadherin-mediated cell-cell adhesion without inhibiting its 
expression. In fact, the effect on adhesion was due to tyrosine phosphorylation of 
catenins and this was transformation specific.
Further evidence for the involvement of E-cadherin in tumorigenesis has also 
come from genetic analysis of tumours. Loss of heterozygosity (LOH) analysis has 
demonstrated that a particular region of human chromosome 16q is often deleted in 
several tumour types, including prostate and hepatocellular carcinomas (Tsuda et al., 
1990; Carter et al., 1990). LOH of 16q has been correlated with tumour progression and 
the deleted region has been narrowed down to 16q22.1, close to the E-cadherin gene 
locus. However, the best evidence has come from two recent studies which screened 
135 endometrial and ovarian carcinomas or tumour cell lines and found a small number 
of E-cadherin mutations (Risinger et al., 1994; Oda et al., 1994). Altogether, the
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functional analysis of E-cadherin in vitro, its altered expression in human tumours and 
the loss of 16q suggest that E-cadherin may be a tumour suppressor involved in the 
development of several types of carcinoma.
A similar correlation was described for another cell surface marker involved in 
cell-cell and cell-matrix interaction - syndecan (Inki et al., 1992). It is lost in poorly 
differentiated tumours but expressed in well-differentiated tumours. There are likely to 
be several surface molecules which maintain the complex three-dimensional structure of 
the stratified epithelial tissues and are absent in mesenchymal cells and epithelial cells 
which have lost differentiation markers. Whether losses of these molecules are the 
initiating events causing loss of differentiation or are merely consequences remains to 
be seen.
1.7 Tyrosine kinases and phosphorylation events affect cell morphology 
and motility
An important function of cell adhesion molecules in addition to adhesive binding 
is transmission of signals across cell membranes. This will have relevance to the altered 
growth state of neoplasia. Study of this process has until recently been limited but it is 
now a subject that is receiving a great deal of attention and advances have been made 
regarding the involvement of adhesion molecules in signal transduction.
Members of all three of the large families of cell adhesion molecules, the 
cadherins, integrins and immunoglobulin-like superfamily, have been shown to 
participate in signalling. Signals can be transmitted from the outside to the inside of the 
cell in response to ligand binding, thus affecting second messengers and gene 
transcription. They can also pass from the inside to the outside of cells, modulating the 
binding affinity of cell adhesion molecules.
Three major enzymatic activities are important in growth factor signalling 
cascades:
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• tyrosine-specific phosphorylation
• phospholipase C activation
• cAMP production by adenylate cyclase
It is the first of these that is most relevant to signalling by adhesion molecules and 
modulation of the epithelial phenotype. Some effectors of epithelial junction signalling 
are receptor tyrosine kinases e.g. the met receptor, FGF receptors and pp60src kinase. 
In addition, some motility and growth factors that activate receptor tyrosine kinases 
(RTKs) disrupt epithelial cell-cell adhesiveness e.g. scatter factor which binds to met 
and aFGF which binds to the FGF receptor. Junctional complexes are major sites of 
tyrosine phosphorylation (reviewed in Lo and Chen, 1994), so altered growth conditions 
can have an effect on these sites.
While cadherins are major participants in cell-cell adhesion, the most important 
complex with respect to cell-matrix contact is the focal adhesion. This complex 
comprises a large number of linked proteins whose activities are modulated by tyrosine 
phosphorylation, a recurring means of control where transmission of signals is 
concerned.
1.7.1 Focal adhesions link the ECM and cytoskeleton
Focal adhesions are specialised regions of plasma membrane where cells adhere to 
the substratum and where actin filament bundles terminate. They are the site where 
integrins and many other proteins are clustered, forming a link between the ECM and 
actin cytoskeleton (figure 5). The involvement of focal adhesions in cell adhesion, 
shape and motility suggests that effectors of focal adhesion may be affected during 
transformation.
Focal adhesions are relatively stable structures but frequently have to be 
assembled and disassembled e.g. during mitosis and migration when cells change shape 
rapidly and become more round. Major reorganisations of focal contacts are thought to 
be responsible for the loss of cell adhesion and accompanying morphological changes
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Figure 5: Relationships between focal adhesion proteins 
and cytoskeletal proteins.
during tumorigenesis since, in general, transformed cells are more rounded and less 
adherent than normal cells. These changes are accompanied by a reduced amount of 
focal adhesion and alterations to actin fibre assembly (reviewed in Kellie, 1988).
Focal adhesions might be sites where external signals such as mitogenic 
stimulation are transduced into the interior of cells. Various stimuli such as growth 
factors and viral transformation have been used to study the signals involved in 
regulating cytoskeletal interactions at focal adhesions. A common feature of these 
factors affecting the cytoskeleton is their activation of kinase activities, suggesting that 
phosphorylation of focal adhesion components could be involved in focal adhesion 
assembly and disassembly. The localisation of v-src and increased phosphotyrosine 
levels in focal adhesion after RSV-induced transformation, (section 1.7.4), imply that 
protein modification may have direct effects on the cytoskeleton but the consequences 
of phosphorylation of focal adhesion proteins remain to be established. One possibility 
is that they provide a binding site for the src homology 2 (SH2) domains of other 
proteins, thus transferring the signal downstream.
1.7.2 Integrins mediate adhesion and signalling
Integrins are the main signalling components of focal adhesions. Many of the 
adhesive interactions of tumour cells are mediated by the integrin family of cell surface 
receptors (reviewed in Hart and Saini, 1992 and Honn and Tang, 1992). Recently they 
have also been implicated in mediating signalling from the ECM to intracellular 
pathways that affect cell proliferation and morphology (reviewed in Damsky and Werb, 
1992 and Schwartz and Ingber, 1994).
Integrins are the predominant family of cell surface receptors for ECM and 
basement membrane components including fibronectin, collagen, laminin and 
vitronectin. They are composed of an a  and [3 subunit and grouped into families 
according to their (3 subunit (reviewed in Hynes, 1992). The (31 and (33 subfamilies bind 
ECM molecules and some integrins show further specificity for individual ECM
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components which are present in the basement membrane of the skin. The basement 
membrane forms the junction between epidermis and underlying connective tissue 
(mesenchyme) and provides the attachment site for the basal layer of the epidermis.
By providing interactions between cells and their ECM, the integrins are believed 
to play a crucial role in tissue formation and maturation in the epidermis (Adams and 
Watt, 1990; Hertle et al., 1991). In vitro studies showed that leaving the basal layer is 
accompanied by a change in integrin function, followed by a loss of expression of a2|31, 
a3|31 and a5(31 (Adams and Watt, 1990).
There have been reports of altered integrin expression in various cell types e.g. the 
decreased expression of integrin a5|31 in some transformed cells (Hynes, 1992), the link 
between a6|34 and malignant squamous carcinomas (Tennenbaum et al., 1993) and up- 
regulation of a5(31 integrin in spindle cell carcinomas (Gomez et al., in press). 
Overexpression of a5|31 integrins in transformed cells can inhibit aspects of their 
transforming behaviour such as slightly increased adhesion to fibronectin, decreased 
growth in soft agar and reduced ability to form tumours in nude mice (Giancotti and 
Ruoslahti, 1990).
These results suggest that changes in the levels of integrin expression are 
important in the interaction of cells with ECM components and impairment of 
interactions between the ECM and its receptors may mediate cell transformation in vitro 
and in vivo. There does not seem to be a simple loss of integrins as tumours progress 
and down-regulation of integrins is not a general characteristic of malignancy. It may 
instead be linked to the acquisition of a more fibroblast-like phenotype and invasive 
capability.
It has become clear that integrins, as components of focal adhesion complexes, 
can participate in signal transduction processes as well as in adhesion. Integrin 
cytoplasmic domains are known to mediate inside-out signal transduction (O'Toole et 
al., 1994) but current knowledge of the signalling through focal adhesions is mostly 
from outside to inside. Integrin-mediated cell adhesion or clustering of integrins on the 
cell surface using antibodies results in the enhanced tyrosine phosphorylation of certain
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intracellular proteins, suggesting that integrins may play a role in a signal tranduction 
cascade (Guan and Shalloway, 1992; Burridge et al., 1992). In cultured fibroblasts, 
carcinoma cells and platelets a cytoplasmic tyrosine kinase (pi25 FAK) has been 
implicated in integrin-mediated tyrosine phosphorylation (reviewed in Schaller and 
Parsons, 1994 and Lo and Chen, 1994).
1.7.3 FAK is a focal adhesion signalling protein
Focal adhesion kinase (FAK) is a major target for tyrosine kinases during various 
cellular events associated with cell adhesion and growth control. It is a cytoplasmic 
tyrosine kinase itself but, unlike most other tyrosine kinases, does not have any SH2 or 
SH3 domains. FAK has been localised to focal adhesions by immunofluorescence 
experiments (Schaller et al., 1992) and shown to be phosphorylated following clustering 
of integrins with anti-integrin antibodies or by plating cells on fibronectin (Hanks et al., 
1992; Komberg et al., 1992). This increase in tyrosine phosphorylation is accompanied 
by an increase in FAK activity measured in vitro (Guan and Shalloway, 1992), 
suggesting that FAK is a downstream transducer of an integrin-mediated signal. 
Attention is now focused on identifying the targets of FAK.
Paxillin and tensin are good candidates. They colocalise with FAK at focal 
adhesions (Davis et al., 1995; Turner et al., 1990) and are phosphorylated in a FAK- 
dependent manner (Schaller et al., 1993). Tyrosine phosphorylation may regulate their 
interactions with other proteins which could be other components of focal adhesions.
FAK has also been implicated as a substrate for v-src and therefore may be an 
important protein in transformation processes mediated by src. The tyrosine 
phosphorylation of FAK is increased in cells transformed by pp60src (Guan and 
Shalloway, 1992) and most of it exists as a complex with pp60src (Cobb et al., 1994). 
However, nothing is known about the way in which the association of these two non­
receptor kinases contributes to transformation. It may cause increased tyrosine 
phosphorylation of focal adhesion proteins which then leads to reorganisation of
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cytoskeletal structures as observed in src-transformed cells (Burridge et al., 1992). 
Indeed, increased tyrosine phosphorylation of tensin, paxillin, vinculin, talin and (31 
integrin have been reported in src-transformed cells (reviewed in Lo and Chen, 1994). 
The complex of activated FAK and src in focal adhesions of transformed cells may also 
promote intracellular signals through pathways normally under the control of cellular 
tyrosine kinases.
1.7.4 V-src causes epithelial-mesenchymal transitions and increased 
invasiveness
V-src is localised in cell-cell and cell-ECM junctions in fibroblasts transformed by 
Rous sarcoma virus (Rohrschneider, 1980). This location is relevant to some of the 
transformation-related effects of v-src.
Activation of temperature-sensitive v-src causes changes in cell morphology and 
increased invasiveness as shown by collagen invasion assays (Behrens et al., 1993) 
although over-expression of c-src alone does not alter cell-cell adhesion (Iba et al., 
1984). V-src causes reversible cell dissociation and its effect is seen in 15min, therefore 
rapid enzymatic reactions rather than changes in transcription or translational control are 
likely to be involved in initial steps. Indeed, the morphological effects of src are linked 
to increased tyrosine phosphorylation of E-cadherin and (3-catenin in MDCK cells 
(Behrens et al., 1993). The same is true in chick embryo fibroblasts (Hamaguchi et al.,
1993). Therefore, tyrosine kinases may regulate intercellular adhesion via modification 
of catenins. This supports the hypothesis discussed previously (section 1.6.6) that loss 
of E-cadherin function, not necessarily expression, is required for transformation.
Src also interferes with cell-substratum adhesion by phosphorylation of integrin 
receptors (Tapley et al., 1989). It is therefore involved in the regulation of formation 
and activity of focal contact complexes. Both forms of src (cellular and viral) are 
physically associated with junctional complex proteins such as focal adhesion kinase,
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FAK; in pp60src-transformed cells, more than 80% of FAK is found as a stable complex 
with pp60src (Cobb et al., 1994).
The link between src transformation and changes in cytoskeletal and membrane- 
bound signalling proteins is an area of intense investigation at the moment but the 
physiological targets of activated c-src have not yet been identified.
Transformation and mitosis both involve major reorganisation of the cytoskeleton, 
possibly by similar pathways. Therefore, studies of the effects of src transformation on 
cell morphology and cytoskeletal components may provide clues to the events that take 
place during mitosis also.
1.8 Growth factors can induce the epithelial-mesenchvmal transition
1.8.1 Acidic fibroblast growth factor and epidermal growth factor modulate 
epithelial cell morphology
Other types of transmembrane signalling can cause changes in cell morphology 
and motility. These are mediated by growth factor receptors which bind acidic FGF or 
EGF. aFGF and EGF both induce the squamous to spindle transition in certain cell lines 
and both act through receptors at the plasma membrane.
As with focal adhesion signalling, tyrosine kinase activity is central to the two 
biological responses to aFGF. Treatment of subconfluent cultures of NBT-II cells 
makes them dissociate and produces individual elongated, motile cells (Valles et al., 
1990a), while confluent cultures enter mitosis (Valles et al., 1990b). Inhibitors of 
tyrosine phosphatases can reproduce the two effects of aFGF, thus providing evidence 
for the importance of tyrosine phosphorylations in this pathway.
EGF has also been reported to induce confluent cultures of rat epithelial cells to 
proliferate and subconfluent cultures to migrate (Blay and Brown, 1985). This 
observation has been extended to human bladder carcinoma cells which also disperse in 
response to treatment with physiological concentrations of EGF (Tucker, pers. comm.).
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A prerequisite for carcinoma spreading and metastasis is the dissociation of the 
tumour mass, allowing some cells to escape and eventually migrate away from the 
primary site of tumour growth. The acquisition of cell motility is accompanied by 
dramatic changes in the program of cell differentiation. Although keratinocytes can be 
motile, the motile cells more often resemble mesenchymal cells which no longer express 
cytokeratin filaments but express vimentin instead. The cell-cell adhesion typical of 
epithelial cells mediated by molecules such as E-cadherin is also reduced (Boyer et al.,
1992), encouraging motility. Cells which have broken through the basement membrane 
are in close contact with connective tissue rich in extracellular components where local 
growth factors, such as EGF and aFGF, produced by endothelial cells may then play a 
crucial part in tumour cell motility by enhancing cell scattering. However, these are not 
the only growth factors that induce scattering.
1.8.2 Scatter factor induces the epithelial-mesenchymal transition
Tyrosine kinase activity is also involved in changes in cell morphology caused by 
scatter factor (SF). SF was initially described as an activity secreted by human embryo 
fibroblasts that caused epithelial cell colonies to dissociate or scatter (Stoker and 
Perryman, 1985). It is identical to HGF which was originally identified as a potent 
mitogen for hepatocytes in culture (Nakamura et al., 1987) and is also mitogenic for 
melanocytes, endothelial cells and epithelial cells (Rubin et al., 1991).
The effects of scatter factor are varied. They include increasing cell motility and 
scattering (Gherardi et al., 1989), induction of the epithelial-mesenchymal transition, 
growth stimulation and growth inhibition (Stoker et al., 1987). SF also promotes the 
invasiveness of human carcinoma cell lines into collagen matrices, suggesting that this 
factor may be involved in tumour metastasis (Weidner et al., 1990).
The c-met proto-oncogene product, a constitutively phosphorylated intracellular 
tyrosine kinase, has been identified as the oncogenic form of the SF receptor (Bottaro et 
al., 1991). It transduces motility, proliferation and morphology signals of SF in
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epithelial cells (Weidner et al., 1993). In situ hybridisation has shown that met is 
expressed in epithelial cells (Chan et al., 1988; Iyer et al., 1995), whereas SF is 
expressed in mesenchyme (Stoker and Perryman, 1985; Weidner et al., 1990). This is 
an example of a paracrine agent mediating the interaction between adjacent epithelial 
and mesenchymal tissues, thus supporting each other's growth requirements. Cell 
dissociation and motility triggered by SF are mediated by the met receptor tyrosine 
kinase (Weidner et al., 1990), in particular its cytoplasmic domain (Komada and 
Kitamura, 1993).
Although expression of SF cDNA in MDCK cells alters cell morphology, motility 
and anchorage-independent growth properties (Uehara and Kitamura, 1992), NIH3T3 
fibroblasts cotransfected with the c-met receptor tyrosine kinase and with its ligand, SF, 
can form tumours with epithelial characteristics (Tsarfaty et al., 1994). Therefore, a role 
for SF in the differentiation and invasion of tumour cells is still uncertain.
1.9 ECM components influence tumour cell morphology
Extracellular signals affecting tumour cell morphology do not always act through 
growth factors; the extracellular matrix itself can be an important influence. 
Extracellular interactions, including the formation of cell-cell junctions and contacts 
with extracellular matrix (ECM) and tissue stroma, are important in regulating 
development and stabilising normal tissues. They are also important in tumours. The 
extracellular environment of tumours is determined by the matrix synthesised by normal 
and tumour cells, as well as host stromal components secreted by surrounding or 
infiltrating host fibroblasts and other normal cells. Components of this ECM and 
stroma can produce signals that are transduced into cells and lead to alterations in gene 
expression and cell phenotype. Therefore, unravelling the molecular pathways by 
which the ECM controls differentiation in epithelial cells is of importance in
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understanding the changes in differentiation states that are a feature of tumorigenesis 
and metastasis.
During tumorigenesis, drastic alterations in intercellular and cell-substratum 
interactions take place; such alterations are particularly evident in tumours of epithelial 
origin. Neoplastic cells are often altered in their response to ECM and stroma (reviewed 
in Ruoslahti, 1992) and when cells are transformed, contact-mediated cell 
communication systems are altered (Mesnil and Yamasaki, 1993). The growth of 
cancer cells is often independent of adhesion to the ECM and a characteristic of 
transformed cells is a reduction in adhesion to solid substrates. This is thought to reflect 
the invasive and metastatic potential of these cells in vivo.
In summary, the environment of tumour cells still influences their characteristics 
and behaviour. It is accessible to soluble growth factors and hormones that modulate 
processes such as differentiation and proliferation. Furthermore, several genes e.g. DCC 
and fa t which were defined as tumour suppressors by virtue of their loss during tumour 
progression code for proteins that are constituents of the ECM (Hedrick et al., 1993). 
Therefore, it seems that the actions of oncogenes and growth factors are insufficient to 
explain carcinogenesis and the effects of ECM components must also be considered.
1.9.1 TGF|3 modulates interactions of cells with their extracellular matrix
The influences of growth factors with their associated tyrosine phosphorylation 
events and the effects of ECM components on epithelial cells have already been 
described. These different aspects of cell-ECM signalling can be connected by one 
growth factor, TGF(3, which can modulate interactions of cells with their environment 
by inducing synthesis of ECM components.
TGF|3 was first described as a soluble factor capable of transforming normal rat 
kidney cells in the presence of TGFa or EGF (Roberts et al., 1981). It is now known to 
have different effects on cell growth depending on the particular cell type and growth 
conditions and has numerous properties including
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• inhibition or stimulation of mitogenesis
• cellular transformation
• induction of ECM component synthesis
• stimulation or reduction of expression of metalloproteinases
• induction of synthesis of proteases inhibitors
• stimulation of integrin expression
• induction of scatter factor expression
The 3 isoforms of TGFp - 1 , 2  and 3 - are expressed in distinct but overlapping 
patterns in most tissues where their biological activities are mediated by the type I and 
type II TGFp receptors. Thus TGFpi exerts a wide variety of biological activities on 
many cells both in culture and in vivo.
The growth of most normal cell lines, whether primary or immortalised, is 
completely inhibited by TGFp. In contrast, most malignant cells are refractory to its 
antiproliferative effects in vitro; malignant carcinomas require much higher levels of 
TGFp to achieve a similar degree of growth suppression and some are only partially 
inhibited, whatever the concentration (Shipley et al., 1986; Wakefield et al., 1987). 
Resistance seems to be a late event in the process of transformation in vitro and 
experimental data suggest that tumour cells in vivo also become refractory at a late stage 
(Haddow et al., 1991; Manning et al., 1991).
Loss of sensitivity to TGFp may be linked to the development of invasive 
properties since overexpression of TGFpl in carcinoma cells is associated with 
tumorigenesis and metastatic spread (Walker and Dearing, 1992; Walker et al., 1994; 
Gorsch et al., 1992).
The crucial properties of TGFp with respect to invasion are connected with its 
involvement in cell-ECM interactions. TGFp can modulate interactions of cells with 
their ECM partly by inducing the synthesis of various ECM proteins. It induces the 
deposition of individual ECM components such as fibronectin and collagens (Ignotz et 
al., 1987) and modifies cell-matrix interactions via integrins (Gailit et al., 1994; Ignotz 
et al., 1989), (Heino et al., 1989). It can also block matrix degradation by reducing the
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synthesis of proteases, while increasing the synthesis of protease inhibitors (Edwards et 
al., 1987). These functions are important in normal cell processes such as wound repair 
and tissue remodelling. TGFp plays an important role in embryogenesis (Heine et al., 
1987) and there is an abundant supply of TGF(31 in wounded tissue where it is spatially 
and temporally regulated (Kane et al., 1991).
One major role of TGFp in these normal situations seems to be the control of 
integrin expression. If this relationship between TGFp activity and integrin expression 
becomes deregulated e.g. in a carcinoma, affected cells may become more motile at 
inappropriate times and locations. As a result, the tumour may have acquired the 
capacity to invade surrounding tissue. Increased degradation of existing matrix 
components may aid this process. Studies of rat mammary adenocarcinoma cells have 
shown that exogenous TGFp may modulate the metastatic potential of mammary 
tumour cells by controlling their ability to break down and penetrate the barrier 
normally formed by the basement membrane (Welch et al., 1990).
1.9.2 Extracellular proteases
As discussed previously, the extracellular matrix influences the development and 
morphogenesis of vertebrate embryos and influences basic cellular processes such as 
proliferation, differentiation, migration and adhesion. A dynamic equilibrium exists 
between synthesis and degradation of the matrix. Degradation is mediated by 
extracellular proteases which digest the ECM on the cell surface (Chen, 1992) and 
metalloproteinases which may have substrate-specific activity e.g. collagenase or more 
general activity e.g. stromelysin. The activity of these enzymes is tightly regulated 
partly by specific tissue inhibitors of metalloproteinases (TIMPs).
Degradation of ECM components by matrix-degrading metalloproteinases 
(MMPs) is normally strictly controlled at multiple levels. The action of MMPs and 
TIMP can be regulated by growth factors and hormones e.g. TIMP expression is 
induced by EGF (Edwards et al., 1987). In neoplasia, regulation can be lost and
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abnormally high levels of expression of some MMPs can be caused by growth factors, 
tumour promoters, oncogenes and hormones (Matrisian and Hogan, 1990).
Other factors can have the opposite effect e.g. TGFp is a potent inducer of ECM 
components and has been shown to affect MMP and TIMP levels in some systems 
(Edwards et al., 1987). TGFp selectively reduces expression of collagenase and 
stromelysin but cooperates with other growth factors to elevate TIMP expression 
beyond its normal level. Therefore, the effects of TGFp are partly due to changes in the 
control of MMP and TIMP expression. This combines with the effects of TGFp on 
matrix synthesis induction to maintain matrix structure.
However, exposure of normal cells to TGFp has the opposite effect to that found 
in transformed cells where TIMP expression is repressed and MMP expression is 
constitutively elevated. Remodelling of the matrix may be required for changes in the 
proliferation, differentiation or migratory state of tumour cells. The changes are needed 
for complex physiological processes such as wound healing or morphogenesis and are 
also evident in cancer. Tumour cell invasion has been proposed to involve a 3 step 
process; tumour cell adhesion, release of ECM-degrading enzymes and tumour cell 
motility. Clearly, extracellular proteases and TIMPs may be involved in the control of 
these processes.
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2.1 Materials
2.1.1 Chemicals
All chemicals were of AnalaR grade and were obtained from BDH Chemicals Ltd., 
Poole, Dorset or Sigma Chemical Co. Ltd., Poole, Dorset except those obtained from 
the suppliers listed below.
Amersham International PLC, Amersham, Bucks
all radioisotopes
rainbow protein markers
ECL Western blotting detection kit
Beatson Institute Central Services
L-broth
sterile PBS
PE
Becton Dickinson Labware, Bedford, MA 
rat tail collagen, type I
BDH
Repelcote
Biogenesis Ltd., Bournemouth 
RNazol B
Boehringer Mannheim UK Ltd., Lewes, East Sussex 
proteinase K
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Taq polymerase
DOTAP transfection reagent
TGFp-1
BRL (UK), Gibco Ltd., Paisley 
all restriction enzymes 
Taq polymerase
J. Burrough (FAD) Ltd., Witham, Essex 
ethanol
Difco Labs., Detroit, Michigan 
Bacto-tryptone
FMC
Nusieve agarose
Gateway pic, Glasgow 
Marvel dried non-fat milk powder
Gibco Europe, Life Technologies Ltd., Paisley 
SLM
lOxDMEM 
foetal calf serum 
200mM glutamine 
2.5% trypsin 
penicillin 
streptomycin 
geneticin (G418)
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Rathbum Chemicals Ltd., Walkerbum 
phenol (water saturated)
Severn Biotech, Kidderminster 
acrylamide (30% and 40%)
Sigma Chemical Co Ltd., Poole, Dorset
Bicinchoninic acid kit for protein concentration determination
epidermal growth factor, EGF (tissue culture grade)
acidic fibroblast growth factor, aFGF (tissue culture grade)
fibronectin
agarose
NP40
Tween20
ethidium bromide
TEMED
(3-mercaptoethanol 
PMSF 
aprotinin 
Na deoxycholate 
EGTA 
orange G 
bromophenol blue 
xylene cyanole 
protein A sepharose
Stratech Scientific, Luton, Beds 
Matrigel
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Vector Laboratories Inc., Burlington USA 
Vectashield mounting medium 
horse serum
2.1.2 Equipment and plasticware
Amersham International PLC, Amersham, Bucks 
Hybond-N membrane
Becton Dickinson Labware, Plymouth, Devon 
tissue culture dishes (60,100mm)
Bibby-Sterilin Ltd., Stoney, Staffs 
bacteriological dishes (60mm)
Biorad
Zetaprobe membrane
Cambridge Electrophoresis 
EV400 gel tank
Eastman Kodak Co., Rochester, New York
x-ray film (XAR-5)
duplicating film
pan F b/w film
Ektachrome colour slide film
Fuji Photo Co. Ltd., Japan 
x-ray film (RX)
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Gibco Europe, Life Technologies Ltd., Paisley
Nunc 1ml cryotubes
Nunc 8-well chamber slides (permanox)
Griener Labortechnik Ltd., Dursley 
Eppendorf tubes
Labsystems, Basingstoke 
pipette tips
Molecular Bioproducts, San Diego CA 
aerosol-resistant tips
Pharmacia Ltd., Milton Keynes 
Nick columns
Schleicher & Schuell, Inc. Dassel, Germany 
SA85 nitrocellulose membrane
Whatman International Ltd., Maidstone 
3MM paper
2.1.3 Antibodies
Affiniti Research Products Ltd., Nottingham 
FAK (mouse monoclonal for immunoblotting only) 
HRP-linked phosphotyrosine
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Amersham International pic, Bucks 
HRP-1 inked mouse Ig 
HRP-linked rat Ig 
HRP-linked rabbit Ig
New Brunswick Scientific 
p62 (rabbit polyclonal)
Sigma Chemical Co. Ltd., Poole, Dorset 
pan keratin (mouse monoclonal) 
vimentin (mouse monoclonal) 
vinculin (mouse monoclonal) 
talin (mouse monoclonal)
RITC-linked phalloidin 
FITC-linked rat IgG 
rabbit anti-mouse IgG
Tissue Culture Services
FAK (mouse monoclonal for immunoprecipitation only)
Upstate Biotechnology Inc., 
phosphotyrosine (mouse monoclonal)
Vector Laboratories 
FITC-linked mouse IgG
a gift from Dr Hans Bos, Utrecht University, Netherlands 
Rapl (rabbit polyclonal)
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a gift from Prof M. Takeichi, Kyoto University, Japan 
E-cadherin, ECCD-2 (rat monoclonal)
2.1.4 Plasmids (figure 6)
p K -r e v i_ i a gift from M. Noda, Japan
pMClneo Stratagene, San Diego, USA 
pECE-GAP-N a gift from T. Pawson, USA
Xho 1455
A TG  7 3 3
pMCIneo Poly A
P o ly  A  
S a l  1 1 5 8 8
ori
S a i l
H in d  III
n e o
pKrev-1
p o ly A ^
B am H I
^ S V 4 0  e a r ly  p r o m o te r
p B R 3 2 2
ori
B am H I
4polyA
P S .I ^  S V 4 0  e a r ly  p r o m o te r  
B am H I  
H in d  III
c D N A
(1 .8 k b )
S S t l
x b a l  I E c o R I
p E C E
(2 .9 k b )
pECEGAP-N
6.9kb
S e a  I
S e a  I
ATG C -S H 2
S H 3E c o R I
FIGURE 6: Plasmids
2.2 Cell culture
All cell lines were maintained in plastic petri dishes or sealed plastic flasks 
containing Special Liquid Medium (SLM) supplemented with 2mM glutamine and 
10% foetal calf serum (FCS). Cells were passaged when subconfluent by aspirating 
the growth media then adding a minimum volume of trypsin solution (10% v/v 
trypsin, 0.01% EDTA in PBS) and incubating at 37°C until the cells detached. 
Trypsin was inactivated by resuspending the cells in serum-containing medium and 
the suspended cells were then reseeded at the appropriate dilution.
2.2.1 Cell lines
A5 spindle explant from the MSC11 carcinoma produced by multiple
DMBA treatment of a mus spretuslmus musculus Fj hybrid mouse 
(single cell clone)
D3
B9 squamous explant from the MSC11 carcinoma produced by multiple
DMBA treatment of a mus spretuslmus musculus Fj hybrid mouse 
(single cell clone)
C5N squamous, non-tumorigenic immortalised cell line isolated by single cell
cloning of MCA3D cells derived by Kulesz-Martin et al., 1983 from a 
Balb/c mouse
SN161 mixed population cell line ( at least 75% squamous) derived from a
lymph node metastasis in a 129/NIH F j hybrid mouse 
carB highly aggressive spindle cell line isolated from a tumour produced
in an NIH mouse after DMBA/TPA treatment
A5, D3, B9, SN 161 and carB were isolated in this lab.
48
Cells were photographed at lOOx magnification using a Nikon Diaphot inverted 
microscope with phase contrast optics and a Nikon 35mm camera back mounted on 
the microscope. The film used was Kodak pan F.
2.2.2 Assessment of tumorigenicity in nude mice
Adherent cells were trypsinised, washed in PBS and resuspended to give 107 cells/ml 
then injected subcutaneously into nude mice using 106 cells per injection site. 
Tumours were harvested when they reached 1cm in diameter in accordance with 
Home Office guidelines.
Tumours were fixed in 10% formalin, embedded in paraffin wax and 7pm sections 
were stained with haematoxylin and eosin according to standard procedures. This 
was carried out by the Glasgow University Veterinary School histology service.
2.2.3 Generation of cell lines from tumours
Tumours were harvested when they reached 1cm in diameter in accordance with 
Home Office guidelines. They were immediately placed in tumour explant medium 
(SLM, 0.1 mg/ml streptomycin, 50units/ml penicillin, 2.5ug/ml amphotericin). 
Under sterile conditions the tumour was finely chopped and pieces placed in a dry 
100mm dish at 37°C to allow the fragments to adhere to the dish. Explant medium 
was then slowly added taking care not to wash the tumour pieces off the dish and the 
explants were incubated at 37°C until sufficient cells had grown out from the 
original tumour mass. Cell lines were obtained by trypsinising and expanding the 
growing tumour cells.
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2.2.4 Cloning
Single cell cloning
Single cell clones were selected by limiting dilution from the uncloned SN161 cell 
line. A suspension of trypsinised cells was diluted to give less than 5 cells/ml. A 96 
well microplate was seeded with this suspension using 200pl per well. Wells 
containing only 1 cell were marked the next day and the rest discarded. Selected 
clones were chosen for expansion.
Ring cloning
Subclones were isolated with cloning rings after microscopic selection for an 
epithelial or fibroblastic phenotype. Cloning rings were placed over the chosen 
colony and held in place using a vaseline seal. Trypsin could then be added to 
remove only this isolated colony.
2.2.5 Long-term storage of cells
All cell lines were stored at -70°C. Subconfluent FI 75 flasks (175cm2 surface area) 
were trypsinised and the cells pelleted then resuspended in 2.5ml growth medium. 
An equal volume of freezing medium (20% DMSO, 25% FCS, 55% growth 
medium) was slowly added and 1ml aliquots of the cell suspension frozen at -70°C 
in freezing vials. The next day cells were transferred to liquid nitrogen for long-term 
storage.
2.2.6 Soft agar assay
Soft agar assays were used to test the ability of various cell lines to grow under 
anchorage independent conditions. Bacto-agar (40ml of 2.5%) was melted in a 
microwave and cooled to 45°C then 20ml of foetal calf serum and 100ml of
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lxDMEM were added. This 0.5% agar solution was kept liquid at 45°C until 
required. Base plates were prepared by pouring approximately 5ml of this solution 
into each 60mm dish. Once the base plates had set, the required number of cells was 
resuspended in 0.5ml DMEM and mixed with 1ml cooled base agar. This agar/cell 
mixture was poured onto a base plate and allowed to set at room temperature before 
transfer to an incubator.
Triplicate plates were used for each cell line and colonies were counted after 2-3 
weeks incubation.
2xDMEM was made with 20ml lOxDMEM
2ml 200mM glutamine
2ml lOOmM Na pyruvate
10ml 7 .5%NaHC0 3
4ml 1M HEPES
58ml sterile H2O
antibiotics
2.2.7 GAP-N transfection of B9 and C5N
5xl05 cells were seeded in 100mm dishes containing SLM + 10%FCS 24-48hr prior 
to transfection. Cell lines expressing the GAP-N protein were produced by 
cotransfection of B9 or C5N cells with pECE.GAP-N and pMClneo. 5pg or lOpg 
of DNA per 100mm dish was introduced by lipofection using DOTAP by the 
recommended procedure. After incubation at 37°C for 24-48hr, the DNA-containing 
medium was removed and the cells were trypsinised and split into 10 dishes then 
grown in selection medium (standard medium plus 400pg/ml G418 (B9) or 
300pg/ml (C5N)).
Selected neomycin resistant colonies were expanded and expression of the GAP-N 
protein was analysed by Western blotting of whole cell lysates using anti-GAP 
antibodies.
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2.2.8 K-rev1 transfection of carB, A5 and D3
5x105 cells were seeded in 100mm dishes containing SLM + 10%FCS 24-48hr prior 
to transfection. Cell lines expressing the K-revl protein were produced by 
transfection of carB cells with pK-revl. 5pg or lOpg of DNA per 100mm dish was 
introduced by lipofection using DOTAP by the recommended procedure. After 
incubation at 37°C for 24-48hr, the DNA-containing medium was removed and the 
cells were trypsinised and split into 15 dishes then grown in selection medium 
(standard medium plus 300pg/ml G418).
Selected neomycin resistant colonies were expanded and expression of the K-revl 
protein was analysed by Western blotting of whole cell lysates using anti-K-revl 
antibodies.
Clones which obtained a flatter morphology upon transfection were selected for 
further analysis.
2.2.9 ECM component assays 
Growth on fibronectin
Fibronectin coated plates were prepared by diluting stock fibronectin (1 mg/ml) to 
30ng/pl in sterile PBS then adding 2ml of this solution to each plate and allowing it 
to coat for 2-3hr at room temperature. Excess fibronectin was removed and the 
plates were then rinsed with PBS and stored at 4°C until required. Trypsinised cells 
resuspended in growth medium were plated at the required density and the effect of 
growth on fibronectin monitored for one week.
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Growth on Matrigel
An aliquot of Matrigel was thawed slowly at 4°C overnight and kept on ice before 
use. Since the matrix gels irreversibly at temperatures above 22°C, all pipette tips, 
plates and tubes were cooled to 4°C prior to dispensing Matrigel. Equal volumes of 
Matrigel and PBS were mixed and minimum volumes of the diluted Matrigel 
dispensed into 24 well plates. The matrix was allowed to set for several hours at 
room temperature then rinsed with PBS before adding cells which had been 
trypsinised and resuspended in growth medium. The multi-well plates were 
incubated at 37°C and the effect of Matrigel on cell morphology monitored for one 
week.
Growth on collagen I
Rat tail collagen type I coated plates were prepared by diluting stock collagen I 
(2.87mg/ml) to 50pg/ml in sterile PBS then adding a minimum volume to each plate 
and allowing it to coat for several hours at room temperature. The plates were 
washed with PBS and stored at 4°C until used. Trypsinised cells resuspended in 
growth medium were plated at the required density and the effect of growth on 
collagen I monitored for a week.
2.2.10 Growth factor treatment
Cells were cultured in SLM containing 2mM glutamine and 5% FCS. Growth 
factors were added to this medium at the appropriate concentrations:
EGF lOng/ml
aFGF25ng/ml plus lOng/ml heparin 
TGFp 5-10ng/ml
The growth factor containing medium was changed every 2-4 days and any 
morphological effect of treatment was analysed further at various time points by 
immunoblotting, immunofluorescence and photography.
2.2.11. Chromosome spreads
Colchicine was added at lpg/ml final concentration to an F25 flask of cells at 75% 
confluence for lhr at 37°C. The medium was then removed, the cells trypsinised and 
resuspended in PBS then pooled with the medium to inactivate the trypsin and 
maintain the metaphase block. The cells were pelleted and carefully resuspended in 
0.5ml hypotonic solution (75mM KC1) which had been prewarmed to 37°C. After 
incubation for 5-10min at 37°C, the cells were again pelleted and the KC1 aspirated. 
Ice-cold 3:1 methanol: acetic acid fixative was added to resuspend the cells and this 
suspension was left for 20min at room temperature. The cells were pelleted and 
resuspended in 3 changes of fixative and finally resuspended in 0.5ml of fixative. 
Spreads were prepared by dropping the cell suspension from a great height onto ice- 
cold microscope slides. Once dry, the spreads were stained with 10% Giemsa.
2.3 Immunoblotting
2.3.1 Preparation of total protein extracts
Whole cell extracts were prepared without trypsin treatment by either of 2 methods.
(a) Extracts containing known numbers of cells per ml were obtained by plating four 
100mm dishes with equal numbers of cells. When subconfluent, the total number of 
cells in one of these dishes was counted. The remaining 3 dishes were washed with 
ice-cold PBS then the cells were lysed in 1ml of lysis buffer (10%glycerol, 5% SDS,
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0.08M tris pH6.8) plus 40pl/ml p-mercaptoethanol added just before use. The 
viscous lysate was removed from the dish using a cell scraper. After boiling, 
sonication (2xl0sec) and centrifugation at 14000rpm for 15min, the lysates were 
adjusted using lysis buffer to give 3x10^ cells/ml. Lysates were stored at -20°C.
(b) Extracts containing equal protein concentrations were prepared by washing 
100mm dishes with ice-cold PBS then lysing in MQ buffer (1% Triton X100, 0.5% 
Na deoxycholate, 0.1% SDS, 0.1M NaCl, 0.05M trisHCl pH7.4, 0.005M MgCl2, 
3mM PMSF ). The lysate was scraped off the dish and, after centrifugation at 4°C 
for 15min, the supernatant protein concentration was measured using the BCA 
method (section 2.3.2) and adjusted to give 600pg/ml.
2.3.2 Protein concentration determination
The protein concentration of whole cell lysates was determined by the BCA method 
which depends on a colour change produced by the reaction between CuS04, 
bicinchoninic acid and protein. Protein samples and standards were plated on a 96 
well microtitre plate and the absorbances read at 562nm automatically. The protein 
content of the samples could then be calculated.
2.3.3 Immunoblotting
Whole cell lysates were prepared as described.
Proteins were separated according to the method of Laemmli (1970) by 
electrophoresis on 8% SDS polyacrylamide gels size 14x14cm.
Gels were loaded with 30pg protein or 0.15xl06 lysed cells per lane plus 5pl of 
rainbow coloured molecular weight markers in 30pl western lysis buffer. All 
samples were denatured by boiling for 3min followed by rapid cooling on ice prior 
to loading. Separated proteins were transferred onto nitrocellulose membranes as 
described by Towbin et al., (1979) for lh20 using a semidry electroblotter.
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PROTEIN SOURCE CLONE/CATALOGUE NO.
E-cadherin M. Takeichi ECCD-2
keratin Boehringer Lu5
vimentin Sigma VIM13.2
talin Sigma 8d4
vinculin Sigma VIN-11-5
phosphotyrosine UBI 05-321
phosphotyrosine Affiniti RC20H
p62 Santa Cruz Bio. sc-108
GAP M. Frame
K-rev1 H. Bos
FAK Affiniti F15020
After completion of transfer, the blot was blocked with blotto (5% powdered milk in 
TBS, 0.05% Tween-20) for at least 2hr. It was then incubated with a minimum 
volume of primary antibody diluted in fresh blotto for the required time. Filters 
were washed 3xl0min in blocking solution and incubated with the appropriate 
horseradish peroxidase conjugated secondary antibody for up to lh  at room 
temperature. Blots were then washed thoroughly 2xl0min in blotto followed by 
2xl0min washing with TBS/tween then immunodetection of antigens on the 
nitrocellulose was performed using enhanced chemiluminescence (ECL).
3% BSA in PBS/tween was used in place of blotto for anti-phosphotyrosine blotting.
The following primary antibodies were used:
E-cadherin mouse monoclonal 1/50000 dilution
keratin mouse monoclonal 1/300000
vimentin mouse monoclonal 1/20000
talin mouse monoclonal 1/20000
vinculin mouse monoclonal 1/20000
phosphotyrosinemouse monoclonal 1/1000 (UBI)
I f 11 1/1000 (Affiniti)
p62 rabbit polyclonal 1/1000
GAP mouse monoclonal 1/250
K-revl rabbit polyclonal 1/2000
FAK mouse monoclonal 1/1000
These were detected using the following HRP-linked secondary antibodies: 
mouse 1/2000-4000 dilution
rat 1/300-1000
rabbit 1/2000-4000
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2.3.4 Immunoprecipitation
GAP immunoprecipitation
Subconfluent monolayers were washed with PBS then lysed in 
radioimmunoprecipitation assay (RIPA) buffer (1%NP40, 0.5% Na deoxycholate, 
0.1% SDS in PBS) containing lx  aprotinin, lpM  Na fluoride, ImM dithiothreitol, 
lpM  (3-glycerophosphate, 1.25mM PMSF, lpM  Na vanadate, ImM Na 
pyrophosphate for 15min at 4°C, scraped off the dish and centrifuged at 14000rpm 
for 15min at 4°C.
The clarified extract was incubated with 5pi of normal rabbit serum and 60pl of 
protein A Sepharose with gentle agitation for one hour at 4°C. After a brief spin to 
remove the protein A sepharose, the total protein concentration of the precleared 
extracts was determined using BCA reagents. Immunoprecipitation was carried out 
with 2pl of anti-GAP antibody per mg protein overnight at 4°C. 60pl protein A 
sepharose was added then pelleted by centrifugation after lhr. The pellet was 
washed 3 times with RIPA buffer then resuspended in 2-fold concentrated Laemmli 
sample buffer and boiled for 5min. The eluted proteins were separated on an 8% 
SDS polyacrylamide gel with molecular weight standards and transferred to 
Hybond-C filters.
The filters were blocked by incubation in phosphate-buffered saline plus 0.05% 
Tween-20 (PBST) containing 3% BSA then the primary antibody, rabbit polyclonal 
antiserum raised against pl20GAP, was added at a 1/4000 dilution for 12 hours. 
Following several washes with 3% BSA in PBST, the filter was incubated with anti­
rabbit horseradish peroxidase (HRP)-linked secondary antibody at a 1/4000 dilution 
for lhr.
After further washes with PBST, ECL detection (Amersham) was performed and the 
filter exposed to x-ray film (Fuji).
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FAK and phosphotyrosine immunoprecipitation
A similar method was used for FAK and phosphotyrosine immunoprecipitation but 
the lysis buffer was 1% Triton, 150mM NaCl, lOmM tris pH 7.4, ImM EGTA, ImM 
EDTA, 0.2mM NaV04, 0.2mM PMSF, 0.5% NP40. The lysate was scraped off the 
dish, clarified by centrifugation at 14000rpm for 15min and the pellet discarded. 
The protein concentration of the supernatant was measured by the BCA method 
(section 2.3.2) and 200-500pg of protein was incubated with l-5pg of antibody and 
immunoprecipitation buffer for up to 24h. 60pl of protein A sepharose was added 
and incubation at 4°C continued with agitation for lh. In the case of the FAK mouse 
monoclonal antibody, the protein A sepharose had to be preincubated with 1/10 
volume of rabbit anti-mouse IgG. The protein A sepharose-protein-antibody 
complex was precipitated by brief centrifugation and the pellet was washed 3 times 
with immunoprecipitation buffer. It was finally resuspended in western lysis buffer, 
boiled and the released proteins separated by SDS-PAGE.
2.3.5 Immunofluorescence
For immunodetection of E-cadherin, 5x104 cells were seeded in 8-well permanox 
chamber slides. Cells were washed in ice-cold PBS then fixed and permeabilised 
with methanol at -20°C for lOmin. They were then washed thoroughly in PBS and, 
after blocking with horse serum for 20min, cells were incubated with a rat 
monoclonal anti-E-cadherin antibody, ECCD-2 (Takeichi), at a 1:500 dilution for lh  
at room temperature. The slides were again washed in PBS/0.15M NaCl/ 0.05% 
Tween-20 and an anti-rat FITC-linked secondary antibody was applied (40 fold 
dilution) for 20min. After further washing in PBS/NaCl/Tween and rinsing in water, 
the slides were mounted with Vectashield antifade using nail vamish to seal the 
coverslips and viewed at 40x magnification using a Leitz fluorescence microscope. 
The same procedure was followed for staining with pan keratin and vimentin 
antibodies. These were used at 1:300 and 1:200 dilutions respectively and the
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secondary antibody was an anti-mouse IgG-fluorescein isothiocyanate conjugate 
used at a 200 fold dilution.
2.3.6 Focal contact staining
Cells were grown in the same way as for E-cadherin immunodetection described 
above and the procedure was the same except that methanol was replaced with 
acetone for cell permeabilisation and fixing. Antibodies against the focal contact 
proteins vinculin and talin (both diluted 1/100) were applied for lhr and, after 
washing, the secondary antibody, a mouse IgG-FITC conjugate in both cases, was 
added for 30min. After incubation with the secondary antibody and washing with 
PBS/salt/TweenJRITC-linked phalloidin (diluted 1/10) was applied for 30min. The 
slides were washed and mounted in the usual way and viewed using a confocal 
microscope. The images were then manipulated to superimpose the FITC and RITC 
fluorescence staining patterns.
2.4 DNA and RNA manipulations
2.4.1 Agarose gel electrophoresis
Flat bed apparatus was used in all cases. 0.5-1% gels (w/v) were cast in lxTAE 
buffer (40mM Tris base, 16mM acetic acid, ImM EDTA, pH8) containing 0.5pg/ml 
ethidium bromide. Low melting point agarose was used for gels from which 
plasmid inserts were to be isolated for use as labelled probes.
Gels were submerged in lxTAE buffer and samples were loaded with 0.25% 
bromophenol blue, 0.25% xylene cyanole, 50% glycerol, lxTAE. Gels for Southern 
blots were run at 30-50V for 15-25hr and low melting point agarose gels were run at 
100V for 2hr. The appropriate molecular weight markers were included on each gel.
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After electrophoresis, the size-fractionated DNA was visualised by ultraviolet light 
illumination and photographed
2.4.2 Restriction enzyme digestion of DNA
Plasmid and eucaryotic DNA were digested in the same way. 5 units of enzyme per 
pg DNA were incubated with the appropriate reaction buffer, ImM spermidine and 
lOOpg/ml BSA as recommended by the enzyme supplier at 37°C for at least 5hr.
2.4.3 Isolation of plasmid insert DNA for use as radiolabelled probes
40pg of plasmid DNA was digested and the insert DNA separated from the plasmid 
by electrophoresis in 1% low melting point agarose. The insert band could be cut 
from the gel when visualised using shortwave UV illumination. The agarose slice 
was mixed with 2x vol water and stored at -20°C until needed for radiolabelling. 
The concentration of insert DNA was estimated using the amount of uncut plasmid 
loaded as a guide.
2.4.4 Extraction of genomic DNA from adherent cells
Subconfluent cells were trypsinised and pelleted at lOOOrpm. The trypsin was then 
removed and the cells resuspended in 1ml of lysis buffer (lOOmM tris pH8.5, 5mM 
EDTA, 200mM NaCl, 0.2% SDS, lOOpg/ml proteinase K). This suspension was 
rotated for several hours at 37°C until clear. DNA was precipitated by adding an 
equal volume of isopropanol then spooled onto a sealed pasteur and washed in 
ethanol. Once dry, the DNA could be resuspended in TE and its concentration 
measured.
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2.4.5 Extraction of RNA from adherent cells
Total RNA was isolated using RNazol, a commercial version of the guanidinium- 
phenol single step RNA isolation method. 3ml of RNAzol was added directly to a 
subconfluent 75cm2 flask of adherent cells, and the lysate scraped off using a sterile 
scraper. This was placed in a 15ml Falcon tube and one tenth volume of chloroform 
was added. After shaking, the tube was placed on ice for 5min then centrifuged at 
4000rpm at 4°C for 15 minutes. The colourless upper phase was transferred to a 
fresh tube, and the RNA precipitated using an equal volume of isopropanol. The 
RNA was then pelleted and washed with 75% ethanol and allowed to air dry. The 
pellet was then resuspended in 50% ethanol in diethylpyrocarbonate (DEPC) treated 
water. Care was taken to ensure that all solutions used were ribonuclease free. RNA 
was stored at -20°C.
2.4.6 Bulk preparation of plasmid DNA
A 10ml starter culture was prepared overnight. This was then added to 500ml of L- 
broth containing lOOpg/ml ampicillin and incubated for at least 16 hrs. The culture 
was centrifuged in 500ml Sorvall bottles at 5000rpm for 5min at 4°C. The pellet 
was resuspended in 25ml of ice cold lysis solution (50mM glucose, 2mg/ml 
lysozyme, 25mM trisCl, lOmM EDTA). After 15 minutes on ice, 50ml of alkaline 
solution (0.2M NaOH, 1%SDS) was added and the solution mixed vigorously by 
vortexing. Finally 37.5ml of potassium acetate solution (3M KAc, 5M acetic acid) 
was added and the bottles incubated on ice for approximately 15min. The bottles 
were centrifuged at 6000rpm, 4°C for 15min. The supernatant was filtered through 
gauze and precipitated with 0.6 volumes of isopropanol. The pellet was resuspended 
in TE.
The plasmid DNA was then further purified by equilibrium centrifugation in a 
continuous CsCi gradient. 1.55g/ml CsCl was dissolved in the DNA solution.
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Ethidium bromide was added to a final concentration of 1 mg/ml. The refractive 
index of the solution was checked to ensure the density of the solution was correct 
(1.55g/ml; refractive index 1.3860). The DNA sample was then loaded into 
polycarbonate tubes and centrifuged at 80000 for 16h at 20°C. After centrifugation, 
the lower red band containing the plasmid was removed from the gradient with a 
syringe. The ethidium bromide was removed from the DNA by extraction with 
butanol. This was repeated until the red colour of the ethidium bromide had 
disappeared.
2.4.7 Southern blot transfer of DNA
10pg of restriction enzyme digested DNA was separated by agarose gel 
electrophoresis and transferred to Zetaprobe nylon membrane by the method of 
Rigaud et al., (1987). Following ethidium bromide staining and photography, the 
size-fractionated DNA was denatured by soaking the gel in 1.5M NaCl, 0.5M 
NaOH, pH13 (2x20min) then neutralised in 1M ammonium acetate, 0.02M NaOH 
(2x20min). The transfer of DNA from the gel to membrane was carried out on a 
raised platform covered with a wick of 3MM paper soaked in transfer buffer. The 
ends of this wick rested in a reservoir of transfer buffer. The gel was placed on the 
wick with Saranwrap surrounding it to minimise evaporation and ensure that all 
capillary action was through the gel and membrane. Zetaprobe membrane was 
placed on top of the gel then covered in 3 sheets of 3MM paper soaked in transfer 
buffer, a stack of paper towels and a weight. Transfer took place overnight then the 
membrane was washed in 2xSSC and crosslinked using a Stratagene UV Stratalinker 
1800.
2.4.8 Northern blot transfer of RNA
Total RNA from adherent cells was isolated by the RNazol method (section 2.4.5).
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Denatured RNA (lOpg) was fractionated on 1% agarose gels using formaldehyde/ 
phosphate buffer and transferred to nylon membranes (Zetaprobe) using lOxSSC as 
described (Sambrook et al., 1989).
2.4.9 Generation of random-primed radiolabelled probes
Labelled probes from double-stranded DNA were made by the random priming 
method. Approximately 50ng of purified insert DNA was boiled for 10 minutes to 
ensure denaturation then cooled and added to a reaction mixture containing 
oligonucleotide labelling buffer, 1.85MBq of a -32P dCTP and 5 units of Klenow 
enzyme and the reaction incubated at room temperature for at least lh.
The unincorporated nucleotides were removed by running the probe through a 
NICK-column (Pharmacia), and its specific activity estimated using a scintillation 
counter.
2.4.10 Hybridisation of labelled probes to Northern and Southern blots
Blots were prehybridised in 0.25M Na2HP04 pH7.2, 7% SDS by brief incubation at 
65°C. Prehybridisation fluid was replaced with hybridisation solution (also 
Na2HP04 pH7.2, 7% SDS) containing the labelled probe and hybridisation was 
carried out at 65°C for approximately 16h. After the required time, hybridisation 
solution was removed and washes with 20mM Na2HP04 pH7.2, 5% SDS (2x30- 
60min) then 20mM Na2HP04 pH7.2, 1%SDS (2x30-60min) were carried out at 
65°C. Washes were repeated until background counts were minimised.
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2.5 PCR
2.5.1 PCR amplification using microsatellites
PCR was performed as described by Love et al (1990). Each 25pl reaction was 
performed with lOOng of genomic DNA in a reaction mixture with 250pM each of 
dCTP, dGTP, dATP, dTTP, 9.25kBq a -32P dCTP, 2 oligonucleotide primers at 
0.1 pM each and 0.5 units of Taq DNA polymerase (from a variety of suppliers) with 
the appropriate buffer containing MgCl2 at 2pM.
All reactions were conducted using a Perkin Elmer GeneAmp PCR thermal cycler 
under the following standard conditions in thin-walled reaction tubes (Perkin Elmer 
Cetus): an initial denaturation step at 95°C for lmin followed by 30 cycles of 
denaturation (95°C, 30s), annealing (50°C or 55°C, 30s) and extension (72°C, 30s) 
then a final elongation step (72°C, 4min). The annealing temperature was varied to 
give the best amplification at highest stringency.
Amplimers were obtained from 3 main sources. Microsatellites most likely to be 
informative were selected using data from the work of Todd et al (Comall et al., 
1991; Love et al., 1990; Heame et al., 1991) and the primers synthesised at this 
institute. Others were obtained from the Human Genome Mapping Project Research 
Centre, Harrow or from Research Genetics, Huntsville, Alabama.
2.5.2 Separation of PCR-amplified products
PCR products were resolved on either 4% agarose or 6% acrylamide gels.
A quick test of the PCR reaction success was carried out using 4% agarose gels 
made with 3% NuSieve (FMC), 1% agarose (Sigma), 0.5pg/ml ethidium bromide 
and TBE buffer. Amplified DNA was loaded with 0.25% orange G in 50% glycerol, 
50% lxTBE and the gels were run for 30min at 100V then photographed.
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6% non-denaturing acrylamide gels formed using 20x38cm glass plates (EV400 gel 
tank, Cambridge Electrophoresis) coated with Repelcote were used for quantitative 
analysis. PCR reaction products were loaded with 50% glycerol, lxTBE, 0.25% 
bromophenol blue, 0.25% xylene cyanole and electrophoresis was conducted at 
room temperature for 2-4 hours at 15W depending on the sizes of PCR fragments. 
The gel was blotted onto 3MM paper, wrapped in Saranwrap and exposed to x-ray 
film (Fuji, RX) overnight at -70°C with intensifying screens.
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Chapter 3 
Results
3.1 Derivation of cell lines with a range of m orphologies
A dramatic change in cell phenotype is sometimes seen in an advanced stage of 
mouse skin carcinogenesis when a relatively well-differentiated squamous cell 
carcinoma progresses to a less differentiated spindle cell carcinoma. As described in 
section 1.4.2, the development of papillomas and carcinomas in stratified epithelium can 
be followed using the mouse skin model system. Most of the carcinomas are squamous 
and retain many of the differentiation features of the tissue of origin e.g. E-cadherin and 
keratin expression. These well-differentiated squamous carcinomas maintain typical 
epithelial tissue structures such as well-developed intercellular junctions and therefore 
are weakly invasive. Spindle cell carcinomas, in contrast, have altered their 
differentiation program and now express many proteins more often linked with 
fibroblasts than epithelia e.g. they have lost E-cadherin and keratin expression and 
express vimentin, an alternative intermediate filament protein, instead.
It is possible that a factor which controls the normal differentiation program of 
epithelial cells is lost in the carcinogenesis process. This is unlikely to be a simple 
switch; it will probably involve a number of stages through intermediates which are 
neither squamous nor spindle. A panel of cell lines has been built up with the aim of 
studying these stages. There are cell lines which have stable squamous or spindle 
morphologies and a number of related cell lines whose morphologies can vary 
depending on their growth conditions i.e. they have a degree of plasticity not seen with 
the fixed squamous or spindle cell lines.
This thesis describes a study of some genetic and epigenetic events that may be 
responsible for the squamous to spindle cell transition using this panel of fixed 
morphology and plastic morphology cell lines.
These studies were designed to provide specific information relating to the control 
of the morphological differences existing between the cell lines tested. It was 
anticipated that such information would provide some clues to the forces controlling the 
squamous to spindle cell carcinoma transition seen in mouse skin tumorigenesis. These
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findings may also have relevance to the control of differentiation in mouse skin 
epithelia. This chapter describes the experimental approaches employed.
3.1.1 Isolation of clonally-related squamous or spindle cell lines with fixed 
morphologies
Two cell lines, A5 and B9, which represent late stages of carcinoma development 
have been isolated (originally identified and isolated by M. Clarke and S. Haddow). 
They were both derived from the same skin tumour, MSC11 (figure 7), which was 
induced in an MSC mouse by DMBA/TPA treatment (carcinogen treatment carried 
out by R. Bremner). This mouse was an Fj hybrid produced by crossing a mus musculus 
female (CBA strain) and a mus spretus male. The use of two distantly related strains of 
mice ensures that their offspring will have a high degree of heterozygosity which is 
ideally suited to genetic analysis and allows the inheritance of maternal and paternal 
alleles to be followed.
A cell line derived from the MSC11 tumour, M SClla, was seen to be a mixed 
population of squamous and spindle cells (figure 8). These distinct components were 
separated by single cell cloning to give 3 clonally-related cell lines: A5 (spindle), B9 
(squamous) and D3 (spindle). The morphologies of these lines have been stable in vitro 
over a long period of time. The relationship between them was demonstrated when it 
was shown that they all possessed the same 3 p53 mutations and one ras mutation 
(Bums et al., 1991). It could therefore be assumed that they originated from the same 
progenitor cell and are probably representative of 2 sequential stages in the 
carcinogenesis pathway. A genetic analysis of the 2 morphologically distinct cell types 
will be discussed in detail in section 3.3.
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N O R M A L  EPITHELIUM
DM B A /T P A  T R E A T M E N T
L O C A L IS E D  T U M O U R  WITH 2  
M O R P H O L O G IC A L L Y  D IST IN C T  
T U M O U R  CELL P O P U L A T IO N S
M S C 1 1 a  C ELL LINE
S IN G L E  CELL C L O N IN G
M U T A N T  H -ras
WILD T Y P E  H -ras
A 5  (S P IN D L E )B 9  (S Q U A M O U S )
Figure 7 : Clonal relationship between squamous and spindle 
cells derived from the same primary tumour
MSC11cl
B9 (squamous) A5 (spindle) D3 (spindle)
Figure 8: M orphology of the parent M SC 11 cell line which  
consists of squamous and spindle components and 3 
single cell clones derived from it.
3.1.2 Isolation of eleven single cell c lones with variable m orphologies
Another source was used for the isolation of cell lines whose morphologies were 
not fixed. A lymph node metastasis from a primary skin tumour in a 129/NIH hybrid 
mouse which had been treated with DMBA and TP A was the source of the SN161 cell 
line (carcinogen treatment and cell line isolation carried out by R. Bremner). This cell 
line comprised a mixed population of cells with morphologies ranging from squamous 
to spindle.
The different morphologies were initially separated by single cell cloning, 
resulting in the production of six new cell lines (figure 9). Three cell lines, G5, SN4 and 
SN8 were uniformly spindle but El and C ll  still seemed to contain a number of 
different morphologies (figure 10). Further single cell cloning of E l, which had a small 
proportion of spindle cells, yielded two more lines, E1N and E4, both of which are 
entirely squamous (figure 11). E4 has the most squamous morphology of all the single 
cell clones and most closely resembles a normal keratinocyte.
The C ll cell line was subjected to ring cloning in an attempt to separate the 
squamous and spindle components; this produced the C llc  and Cl Id cell lines both of 
which still had a variety of cell types (figure 10). Further single cell cloning of C l Id 
produced the B8, H9 and H ll  cell lines (figure 11). B8 is similar to C llc  and C l Id i.e. 
it exists as squamous colonies surrounded by dissociated spindle cells; H9 is flat but not 
truly epithelial; H ll  is spindle but, after long periods in culture, small squamous 
colonies begin to appear.
It was therefore concluded that some of these cells are truly plastic i.e. it is not 
always possible to isolate a line with a uniform morphology. Indeed, the morphology of 
these cell lines can be altered experimentally by methods which will be discussed in this 
chapter.
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SN161
LYMPH NODE METASTASIS
I
SN161 CELL LINE
SINGLE CELL CLONING
RING CLONING
SINGLE
CELL
CLONING
SINGLE
CELL
CLONING
Figure 9 : Derivation of SN161 cell line and isolation of 
11 single cell clones
C11d
B
B  ^ t a V  iv l! a s
SN4 SN8
Figure 10: Morphologies of single cell clones derived from  
the SN161 cell line.
SN161
H9
B8
Figure 11: M orphologies of single cell clones and the parent 
SN161 cell line from which they were derived.
3.2 Biological characterisation of cell lines
3.2.1 Detection of E-cadherin, vimentin and keratin in A5 and B9
The expression of markers that distinguish epithelial and fibroblast-like cells was 
determined in A5 and B9 by immunocytochemistry and Western blotting. As would be 
expected, the squamous cell line, B9, expresses typical epithelial markers such as E- 
cadherin and cytokeratins (figures 12, 16 and 17).
These cytokeratins are probably K5 and K8; A5 was previously shown to express 
K8 by using a K8 specific antibody (Stoler et al., 1993). K5 is a typical marker of 
epithelial cells but K8 is not normally expressed in adult epidermis; it is usually 
associated with the early stages of embryogenesis. It can, however, be re-expressed in 
skin carcinomas induced by expression of mutant ras as a result of chemical 
carcinogenesis protocols.
A5 is a spindle cell line that has lost epithelial markers such as E-cadherin and 
instead shows a more fibroblast-like program of differentiation e.g. by expressing 
vimentin as shown by immunocytochemistry and Western blotting. It still retains some 
expression of cytokeratins but produces only the lower molecular weight cytokeratin 
(figures 12 and 17).
The C5N cell line has been included in some cases as a control for epithelial- 
specific markers. It more closely resembles a normal keratinocyte than B9 as shown by 
its expression of only the higher molecular weight cytokeratin (figure 17). The C5N 
cell line is not related to the MSC cell lines or the panel of SN161-derived cell lines.
3.2.2 Detection of E-cadherin, vimentin and keratin in SN161 clones
The same analysis was carried out for the eleven SN161 clones. 
Immunofluorescence studies showed the E-cadherin, vimentin and keratin expression 
patterns that would be expected on the basis of their morphologies. Cell lines which
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A5 VIMENTIN
B9 E-CADHERIN
B9 KERATIN
Figure 12: C harac terisa tion  of A5 (spindle) and  B9 (squam ous) 
by im m unocytochem istry . A5 expresses vim entin while B9 
expresses k era tin  and  E -cadherin . These expression p a tte rn s  
have been confirm ed by W estern  blotting ( figures 16 and 17).
consisted of varying proportions of squamous colonies surrounded by individual spindle 
cells showed areas of positive staining for E-cadherin surrounded by negative areas 
(figure 13). Positive immunofluorescent staining was dependent on the existence of 
close cell-cell contacts and was therefore observed only in confluent cultures of 
epithelial cells or within small squamous colonies in low density cultures. It was absent 
where there were no neighbouring cells or where adjacent cells were fibroblast-like.
Staining patterns for keratin and vimentin were reverse images of each other. 
Keratin intermediate filaments were present in squamous cells whether in close contact 
with their neighbours or sparse (figure 14), while a vimentin network could be seen in 
fibroblast-like cells (figure 15). Some cross-reactivity between the keratin antibody and 
vimentin expressing cells was occasionally observed. High background staining due to 
an excess of antibody resulted in low level staining of cells which would normally be 
negative e.g. C l Id as shown in figure 14. Cell lines comprising of a range of 
morphologies had distinct areas of positive staining for each type of intermediate 
filament; squamous colonies were positive for keratin while surrounding spindle cells 
within the same culture were positive for vimentin. This indicated that the two different 
cell types had adopted alternative differentiation programmes and keratin and vimentin 
intermediate filament networks are, in this case, mutually exclusive.
Immunoblotting studies supported these findings. Squamous SN161 cell lines 
expressed E-cadherin and the lower molecular weight cytokeratin while spindle lines 
expressed vimentin and had lost E-cadherin expression (figures 16 and 17). The lower 
molecular weight bands in B9, C llc  and E l lanes on E-cadherin probed blots (figure 
16) are due to partial degradation of the protein in some cell lysates. Vimentin 
expression in SN161 and B8 is not seen in figure 17 due to the low percentage of 
spindle cells in the lysate but it can be detected with a longer exposure (not shown). It 
is interesting that all of the SN161 clones that express keratin produce only the lower 
and not the higher molecular weight keratin which is the major keratin seen in the 
epithelial lines B9 and C5N. This may indicate that the SN161 clones are representative 
of a more advanced stage of tumorigenesis.
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E4
H9
S P I N D L E
S Q U A M O U S
B8
H9
B8
F igu re  13: D etection of E -eadherin  by im m unocytochem istry . E4 and  
E1N a re  positive th ro u g h o u t the population  w here cells a re  confluent. 
A fter long periods in cu ltu re , B8 and  H9 begin to show regions of 
positively s ta in ing  squam ous cells su rro u n d ed  by negative spindle 
cells.
Figure 14: Detection of keratin  interm ediate filament netw ork  by 
im m unocytochem istry. E l and E4 are  positive. C l lc  and C l Id 
have positively staining squam ous colonies surrounded  by negative 
spindle cells.
SN4 SN8
SPINDLE
S Q U A M O U S
SPINDLE
SQUAMOUS
SN161 SN161
F ig u re  15: D etec tio n  o f vimentin in te rm e d ia te  f ilam en t n e tw o rk  by 
im m u n o cy to c h em is try . SN 4, SN8, G5 a n d  H I 1 ex p ress  v im en tin . 
SN161 h a s  positive a n d  n eg a tiv e  reg io n s  d e p e n d in g  on th e  cell 
m o rp h o lo g y ; sq u a m o u s  co lonies a r e  n eg a tiv e  w hile s u r ro u n d in g  
sp in d le  cells a r e  positive.
Figure 16: E xpression  of E -cad h erin  p ro te in  in S M 61  clones 
and  o ther squam ous and  spindle cell lines derived  from  m ouse 
skin tum ours. T he expression  p a tte rn  is consistent w ith th a t 
p red ic ted  by the m orphology of each cell line i.e. squam ous 
cells a re  positive and  sp indle cells a re  negative.
The low er m o lecu lar w eight bands in the up p er gel a re  
deg rad atio n  p ro d u c ts  of the E -cad h erin  p ro te in .
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Figure 17: Expression of cy tokeratin  (CK) and vimentin interm ediate 
filam ent proteins in SN161 clones and o ther squamous and spindle 
cell lines derived from  mouse skin tum ours. Squamous cell lines 
express keratin  while spindle cells express vimentin. Cell lines with 
mixed morphologies express both.
3.2.3 Assessment of tumorigenicity and anchorage-independent growth
It has been frequently observed that spindle cells are more tumorigenic than their 
squamous equivalents and the more advanced a cell type is with respect to its position 
on the carcinogenesis pathway, the more tumorigenic it tends to be. Each of the SN161 
cell lines was injected into nude mice in order to test this relationship between 
tumorigenicity and cell shape. The results obtained show a general trend linking 
morphology and latency (table 2). The most spindle clones (H ll, SN4 and SN8) 
produced tumours of 10mm diameter in 35-43 days, while the most squamous of the 
clones, E4, grew much more slowly and took 76 days to produce a tumour of similar 
size. These figures are, however, only a rough guide since there is a degree of error 
involved in deciding when a particular tumour is of the appropriate size; some tumours 
protrude from the skin surface more than others. With the exception of E4, all of the 
cell lines induce tumour formation in a relatively short time when compared with the B9 
cell line which was derived from a squamous cell carcinoma (6 weeks).
A common property of transformed cells is their ability to grow in semi-solid 
media. This property often correlates with a spindle morphology so 5 of the SN161 
clones were tested for their ability to grow in soft agar (table 3). As would be predicted, 
the squamous clones (E1N and E4) did not grow. In contrast, lines that contain a 
proportion of spindle cells (H9, H ll  and B8) had varying abilities to grow and the most 
spindle of these, H ll, grew as well as the spindle cell line, A5. Two explants derived 
from nude mouse tumours induced by SN161 clones (El-3 and G5-23) were also tested. 
E l-3 (a squamous cell line) grew poorly despite being derived from a spindle tumour, 
although it may have an enhanced growth compared to the original El cell line which 
was not tested. G5-23, a mainly spindle explant from a tumour induced by injection of 
the spindle cell line, G5, grew slightly better but still did not produce the same number 
and size of colonies as other spindle cell lines.
It seems that a growth-promoting factor which is present in vivo, is absent in the 
conditions used to test anchorage-independent growth in culture.
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CELL
LINE
ORIGIN & 
MORPHOLOGY
COLONY 
FORMATION 
IN SOFT AGAR
A5 spindle clone from skin tumour +++
EIN squamous clone from metastasis -
E1-3 squamous explant from tumour induced 
by injection of E1 (squamous) +
G5-23 spindle explant from tumour induced by 
injection of G5 (spindle)
++
H9 mixed morphology clone from metastasis
++
H11 spindle clone from metastasis +++
E4 squamous clone from metastasis
-
B8 mixed morphology clone from metastasis +
C5N squamous cell line
-
TABLE 3:
Assessment of anchorage independent growth of various cell lines with a 
range of morphologies. The ability to grow in soft agar was determined 
by measuring 2 factors : the number of colonies and their size. Cell lines 
which were unable to grow under these conditions are indicated -. Cell 
lines which produced approximately 50 colonies of 100 cells are indicat­
ed + (weakly positive), those which produced more than 100 colonies of 
about 100 cells are indicated ++ and those which grew as well as the 
positive control, A5, (more than 100 colonies of more than 100 cells 
each) are marked +++.
3.2.4 Demonstration of morphological plasticity of metastasis-derived cell 
lines
As described in section 3.2.3, SN161 parental cells produce spindle tumours when 
injected into nude mice despite being comprised of a majority of squamous cells. It was 
not known if this was due to dominance of the minority of spindle cells in vivo or if the 
whole population had switched to a more spindle phenotype induced by environmental 
factors in the host tissue. This question was addressed by injection of the SN161 clones 
which have a variety of morphologies.
The histology of all tumours induced by SN161 single cell clones was spindle 
even when the cell line injected was uniformly squamous e.g. E1N. However, when 
explants were grown from these tumours, squamous cells could be recovered if the cell 
line injected had a squamous component; explants from tumours induced by spindle cell 
lines were mostly spindle (figure 18).
The origin of the tumour explants was confirmed by PCR. The cell lines injected 
were initially isolated from a 129/NIH hybrid mouse tumour, a genetic background 
which can be distinguished from the nude mice used to test tumorigenicity. Four 
microsatellite markers (D2MIT22, D2MIT26, D9MIT9 and D9MIT11) showed 
amplification of 129 and NIH alleles using explant DNA (figure 18) so it can be 
assumed that the tumours are derived from injected cells and their spindle morphology 
is not due to host fibroblast recruitment.
This supports the theory that the cell lines have a plastic morphology that can be 
modulated by factors in the subcutaneous environment where they were injected. These 
factors presumably are not present in vitro because a significant proportion of the cells 
which were altered in vivo regain their original squamous morphology in culture. It is 
also possible that in vitro growth conditions encourage the squamous morphology.
A valuable resource has now been created which will be extremely useful in the 
study of both carcinogenesis and epithelial differentiation. A great deal is known about 
the phenotypes of squamous and spindle cell lines such as A5 and B9 and various events
72
G5-23 E1N2-2
yirK 'AW  - ^ £ jf ^ . . i  £ > •*  i* .' ^ .'•<*,i»' :? .*vi > 4^1 ' •’C ^ C  # « % ?£!£z %-*#*•»*!
t / .  i % > < o  r A
‘A 't f ;  4  ^  k V  ,<»’ » .  •  ,^ .'« 5  • *  * -^ '  i.-* ''T 'V ^ T '
SN4-1 SN161-2
Figure 18 : E xplan ts from  nude m ouse tum ours. S q u am o u s cells can 
be recovered from  spindle tu m o u rs  if the inoculated cell line h ad  a 
squam ous co m p o n en t T he relationship  of the exp lan ts to the  in jected  
cells is proven by PC R  of 129/NIH m ark ers .
that occur during carcinognesis. Now another aspect has been introduced; cell lines 
which are capable of altering their morphologies in response to signals from their 
environment. These cell lines may represent an intermediate stage which lies between 
the squamous and spindle extremes and possesses the ability to alter its morphology 
transiently. Using all of the cell lines now characterised, it should be possible to 
identify both genetic and biochemical factors central to the squamous/spindle transition.
3.3 Genetic analysis of fixed morphology cell lines
Numerous studies have indicated the importance and causal nature of genetic 
alterations in carcinogenesis. Neoplastic cells accumulate increasing numbers of genetic 
alterations generated by random somatic mutational events (Nowell, 1976) and the more 
genetic changes tumours undergo, the more malignant they become (Vogelstein et al., 
1989). Specific alterations have been associated with particular stages e.g. ras and p53 
mutations and it is now evident that many of these alterations can be detected as gross 
chromosomal changes.
The recently developed technique of mapping using microsatellites as markers has 
been adapted to provide a means of allelotyping mouse skin tumours. It is much more 
sensitive than karyotyping and can detect relatively small genetic alterations. It has 
been applied to the mouse skin model system with the aim of identifying alterations 
specific to the squamous/spindle transition.
3.3.1 Summary of allelotype
On the basis of previous work carried out on A5 and B9, it was thought that some 
of their phenotypic differences were due to the loss of a gene with tumour suppressing 
properties. Indirect evidence from cell fusion studies showed that the spindle phenotype 
was recessive and the tumorigenicity of spindle cells could be suppressed to some extent
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depending on the morphology of the cells they were fused with (Stoler et al., 1993). 
This suggested that a loss of information had occurred during the progression from 
squamous to spindle carcinoma.
A5 and B9 were derived from a tumour induced in a CRPdmus spretus FI hybrid 
mouse. The hybrid has a high degree of heterozygosity which can be exploited to 
search for loss of heterozygosity which is often a good indication of the presence of a 
tumour suppressor gene at that locus. The purpose of this study initially was to identify 
gross chromosomal alterations, not specific genetic changes relating to particular genes. 
Genetic changes affecting specific genes e.g. the H-ras oncogene have already been 
reported in this system (Quintanilla et al., 1986; Bremner and Balmain, 1990) and will 
not be discussed here.
Many markers were screened under different reaction conditions to find those 
which were most informative i.e. were polymorphic for MSC mice. Typical results of 
microsatellite analysis using a variety of DNA samples and polymorphic markers are 
shown in figure 19. Using D7MIT17, spretus and musculus DNA give products of 
different sizes so this marker can be used for spretus/musculus hybrids e.g. MSC. The 
same is true for 129/NIH and spretus/NIH crosses since each parental product can be 
seen. The marker is not informative for sencar/Balb crosses since both of these strains 
give products of the same size.
Examples of balanced and imbalanced alleles are also shown in figure 19. The 
DNA samples tested were isolated from cell lines and spleen tissue. The A5, B9 and D3 
cell lines were single cell cloned from the MSC 11 cell line (MSC 11 cl), a cell line 
derived from the M SC lla tumour (figure 7). MSC 11 cl exists as a population of mixed 
morphologies, approximately 75% squamous and 25% spindle. It was therefore 
anticipated that the results for B9 and MSC 11 cl should be very similar and the allelic 
ratios found for M SCllcl should equal the combined ratios for A5, B9 and D3.
Primer D9MIT9 shows that A5, B9 and D3 have the same result as control spleen 
DNA i.e. the lower spretus allele amplifies better than the CBA allele. Primer 
D13MIT14 shows that genetic alterations have taken place in A5 and B9. The spleen,
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C: ALLELIC IMBALANCE (pr imer  D13MIT14)
F ig u re  19: T y p ica l re su lts  fro m  P C R  am p lif ic a tio n  o f 
p o ly m o rp h ic  m ic ro sa te llite s .
A: S c re e n in g  fo r  p o ly m o rp h ism s using  p r im e r  D 7 M IT 1 7  
sh o w ed  th a t  it w as in fo rm a tiv e  fo r  M S C , 129/N IH  a n d  S P R /N IH
crosses.
B: P r im e r  D 9 M IT 9  show s th a t  all DNA sam p les  give th e  sam e  
ra tio  o f  a m p lif ied  p ro d u c ts
C : P r im e r  D 1 3 M IT 1 4  show s th a t  th e  B9 cell line h as  a n  im b a la n c e  
in fa v o u r  o f th e  s p re tu s  allele
MSC11 tumour DNA (MSC11T) and M SCllcl DNA samples show preferential 
amplification of the larger spretus allele but A5 has the opposite ratio and B9 has lost 
nearly all of the CBA product. It is important that results are always compared to spleen 
samples because amplification of one marker more than the other may be due to the 
reaction conditions and primer design rather than the genetic composition of the DNA 
sample.
Control DNAs from inbred spretus and CBA mice were tested with the MSC11- 
derived DNAs to show which allele in the hybrid samples could be attributed to which 
parent. However, some results were complicated by the fact that all of the primers were 
designed for musculus sequences. The most important region for Taq polymerase is the 
3' end of the primer which must be a good match with the genomic sequence to which it 
should bind in order to allow Taq polymerase to extend the oligonucleotide. In some 
cases the spretus sequence varies significantly from musculus, therefore the allele does 
not amplify - the marker is then "not informative". In other cases the spretus allele does 
amplify but the spretus product size varies between control spretus DNA and MSC 
hybrid DNA. This is due to some variation between individual spretus mice which are 
not inbred. The same can be true for the musculus allele (CBA in this study) although it 
varies much less often. It is important to bear this variation in mind when analysing the 
PCR products. For this reason, control spleen DNA samples were included to check 
that individual primers were informative. These were prepared from different mice as 
indicated by their number i.e. MSC2spl, MSC7spl etc. These are only useful as proof 
that both alleles amplify since individual spleen DNAs can sometimes produce differing 
ratios of products with the same primers despite being "normal" controls.
Further complications can be created by shadow bands. These are caused by 
strand slippage during PCR and can eliminate potentially useful markers e.g. the spretus 
product shadow band may be the same size as the musculus band which is then masked. 
In many cases, however, this can be avoided by using appropriate gel running 
conditions.
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Microsatellite allelotype analysis of A5 and B9 using polymorphic markers has 
identified genetic differences which distinguish the two cell lines. As shown in table 4, 
of the 147 markers examined (5-19 per chromosome), those on chromosomes 3, 4, 7,13, 
16 and 17 showed that all 3 cell lines differed from spleen DNA. Only the spindle cell 
lines, A5 and D3, differ from spleen on chromosomes 1, 5, 12 and 19 and only the 
squamous cell line, B9, differs from spleen on chromosomes 6, 8 and 18. There were no 
differences between squamous and spindle cell lines on chromosomes 2, 3, 7, 9, 10, 15 
and 17. Therefore, the genetic alterations that distinguish the squamous and spindle 
lines involve chromosomes 1, 4, 5, 6, 8, 12, 13, 16, 18 and 19. In most cases it was 
either the squamous or spindle cells that differed from spleen but markers on 
chromosomes 13 and 16 identified different alterations in A5/D3 and B9.
This is a simplified presentation of the allelotype since certain individual markers 
give results inconsistent with other markers on that chromosome; these will be discussed 
later. Further complications are due to differences between the two spindle cell lines 
e.g. on chromosomes 11 and 14 where only A5 differs from spleen. For the purposes of 
this study, only alterations that distinguish both spindle cell lines from the squamous 
cell line have been regarded as significant.
Strikingly, out of all 118 informative markers analysed, there was only one 
complete loss of heterozygosity at D8MIT13 (figure 20). All other markers on this 
chromosome produced both alleles. This contrasts dramatically with the larger number 
of allelic imbalances found. It is even more interesting that the loss has occurred in B9, 
not A5. It seems to be a local deletion but the precise region of loss has not yet been 
investigated.
Some individual markers showed large imbalances not seen with flanking 
markers. For example, the D3 cell line result with D9MIT16 shows much greater 
amplification of the musculus allele than the spretus allele (data not shown). This is in 
contrast to the result for A5 and B9 at this locus and the result for all cell lines at all 
other markers on this chromosome. It is not possible to say with certainty whether D3 
has lost spretus or gained musculus alleles since PCR amplification only shows relative
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CHROMOSOME
ALL CELL LINES 
DIFFER FROM SPLEEN
ONLY A5 & D3 
(SPINDLE) DIFFER 
FROM SPLEEN
ONLY B9 
(SQUAMOUS) 
DIFFERS FROM 
SPLEEN
1 •
2
3 ▲
4 ▲ ■  (1 )
5 •
6 ■
7 ▲
8 ■ (2)
9
10
11 •  (3)
12 •
13 ▲  (4)
14 •  (3) ■
15
16 A (4)
17 A
18 ■
19 •
TABLE 4: Summary of A5, B9 and D 3  allelotypes indicating gross 
chromosomal alterations
(1) B9 has undergone further alteration (recombination) not s e e n  in A5 and D3
(2) B9 has com plete LOH at D8MIT13
(3 )  only A5 differs from sp leen
(4 ) squam ous and spindle cell lines have different alterations.
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F ig u re  20: A nalysis of chrom osom es 8, 16 a n d  18. D 8M IT 13  
show s th e  only com plete  loss o f heterozygosity  fo u n d  i.e. B9 
has lost the  CBA allele. D 16M IT 2  an d  D 1 8 M IT 9  show  a 
d iffe ren ce  betw een  B9 an d  A 5/D 3; in both  cases B9 has 
an  im b a lan ce  in fav o u r of the  sp re tu s  allele w hile A5 an d  
D3 have an  im b alan ce  in fav o u r of the  CBA  allele.
amounts of the two alleles. The situation is further complicated by the degree of 
aneuploidy of the cell lines; A5 and B9 are tetraploid as determined by karyotyping 
(data not shown).
3.3.2 Detailed analysis of chromosomes 6,16 and 18
Alterations found on particular chromosomes have interesting implications for the 
study of mouse skin carcinogenesis. Indeed some can be linked to genes already known 
to be directly involved in tumorigenesis. In accordance with published results from 
primary tumours also obtained using the mouse skin model system (Kemp et al., 1993), 
chromosome 6 was shown to have an imbalance at all markers tested (figure 21). In 
every case, the spretus allele was under-represented in B9. The degree of imbalance 
suggests that trisomy of chromosome 6 has occurred with the CBA allele being 
duplicated in B9: A5 and D3 were normal with respect to spleen DNA. Chromosome 6 
harbours several genes which have relevance to the carcinogenesis process e.g. K-ras, 
raf-1 and met.
Chromosome 16 markers showed that B9 has an over-represented spretus allele 
compared to A5 and D3 (figure 20). All markers produced this result. Mouse 
chromosome 16 has regions of homology with human chromosomes 3, 16, 21 and 22. It 
is not clear what significance this has with regard to tumour development.
Chromosome 18 markers showed that B9 again has an over-represented spretus 
allele compared to A5 and D3 (figure 20). All markers produced this result. Mouse 
chromosome 18 has regions of homology with human chromosomes 5, 10 and 18. 
These are the locations of the APC, MCC and DCC genes which are known to be 
mutated in human tumours and may have relevance to mouse carcinogenesis also.
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Figure 21: Markers on chromosome 6 show an imbalance  
in favour of the musculus allele in B9.
3.3.3 Detailed analysis of chromosome 4
The most interesting imbalance with respect to skin carcinogenesis is on 
chromosome 4 (figure 22). All 3 cell lines have suffered a trisomy in favour of the 
musculus allele and B9 has a further alteration (possibly a recombination) affecting a 
distal portion of the chromosome distinguishing it from the spindle cell lines. In each 
cell line, all markers between D4MIT4 and D4MIT13 show the same imbalance in 
favour of the musculus allele but, in B9, markers distal to D4MIT13 (69cM) i.e 
D4MIT59, T51, T81 and T35 show an increased amplification of thq spretus allele with 
respect to CBA. It is reasonable to assume this indicates that a recombination has taken 
place between markers D4MIT13 at 69cM and D4MIT59 at 80cM in B9 and M SCllcl 
but not in A5 or D3.
This genetic difference is significant because other studies of mouse skin tumours 
have shown loss of heterozygosity on chromosome 4 in advanced carcinomas. Mouse 
chromosome 4 has some homology with human chromosome 9 which has been 
implicated in various types of cancer, but the changes found in A5 and B9 are distal to 
these regions. The region involved in the putative recombination is syntenic with 
human chromosome lp34 and lp36.
Marker D4MIT31 results (not shown) have been treated with caution since they 
show what may be an anomalous result at 48cM. All neighbouring markers show an 
imbalance in favour of the musculus allele with respect to control spleen DNA while 
D4MIT31 shows a relative increase in proportion of spretus products in A5 and D3. It 
is extremely unlikely that a double recombination has occurred in this small region 
although the imbalance may be due to a localised amplification in the spindle lines. 
Another possible explanation is that the marker has been incorrectly mapped.
The same analysis has been applied to the panel of SN161-derived clones using a 
limited number of markers. Interestingly, the genetic alterations distinguishing the 
squamous and spindle cell lines, A5 and B9, have not been found in these cell lines 
(data not shown).
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F ig u re  22: D eta iled  an a ly s is  o f  ch ro m o so m e  4. All m a r k e r s  p rox im al 
to D 4 M IT 1 3  show  a n  im b a lan ce  in fa v o u r  o f  the  m u scu lu s  allele in all 
cell lines. A re co m b in a t io n  seem s to  h av e  o c c u r r e d  b e tw een  m a r k e r s  
D 4 M IT 1 3  an d  D 4 M IT 5 9  in B9 bu t  not A5 o r  D3.
3.3.4. Relationship betw een A5, B9, D3, MSC11cl and MSC11T
3.3.4A Imbalances A5 has with respect to B9
At first glance there seem to be many differences distinguishing the squamous B9 
from spindle A5. On closer examination, however, these can be simplified to give an 
overall picture of relatively few differences. A5 differs from B9 at all markers on 
chromosomes 1, 5, 6, 11, 12, 13, 14, 16, 18 and 19. In some cases these differences are 
likely to be due to whole chromosome imbalances but this can not be assumed without 
further investigation. There are some interesting differences on chromosomes 4 and 8 
which have already been discussed (sections 3.3.3 and 3.3.1). Isolated differences 
affecting only part of a chromosome are rare and can not be linked with specific 
candidate genes. At present there are only 4 examples of this: D3MIT16, D8MIT13, 
D15MIT16 and T30 (chromosome 15).
At D3MIT16, B9 has equal amplification of both alleles while all other markers 
on chromosome 3 show over representation of the spretus allele. A5 and D3 produce 
the same result at all markers i.e. preferential amplification of spretus. It is not yet clear 
what significance this result has.
D8MIT13 is the only primer in this study of 118 informative microsatellite 
markers which shows a complete loss of heterozygosity. As shown in figure 20, B9 has 
completely lost the CBA allele which is retained in A5 and D3. Flanking markers 
produce both products. It is interesting that the loss has occurred in the squamous but 
not the spindle cell lines. The precise region of loss has not yet been determined.
There are 2 markers on chromosome 15 which produce different results for A5 
and B9. D15MIT16 and T30 show an increased amplification of the spretus allele in B9 
compared with A5. This is true for two out of seven of the markers tested on this 
chromosome. The significance of this result, if any, has not been examined further.
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3.3.4B Differences betw een A5 and D3
In contrast to the significant number of differences between A5 and B9, there are 
few differences between A5 and D3. These two cell lines differ at only 4 individual 
markers (D9MIT16, D12MIT11, D12MITS2 and D15MIT17) plus all 4 markers on 
chromosome 14 where A5 and B9 have completely lost the spretus allele while it is 
retained in D3. This small number of differences is encouraging because it suggests that 
the genetic differences found between A5 and B9 are likely to be related to the varying 
cell morphologies and are not due to genetic instability in culture over long periods of 
time. The same outcome is obtained with A5 and D3 at 110 out of a total 118 markers 
despite their being cultured separately after the initial single cell cloning. In this 
respect, the technique of microsatellite analysis has been successful in detecting gross 
chromosomal alterations while giving reliable and reproducible results.
3.3.4C Differences between B9 and MSC11cl
MSC 11 cl is the parent cell line from which A5, B9 and D3 were cloned. It exists 
as a population of mixed morphology cells, approximately 75% of which are squamous. 
It was therefore anticipated that the results for B9 and M SCllcl should be very similar 
and the allelic ratios found for M SCllcl should be equal to the combined ratios for A5, 
B9 and D3. In most cases this is true. However, B9 differs from M SCllcl at 5 markers 
(D3MIT16, D8MIT13, D15MIT16, D16MIT7 and T30 on chromosome 15) plus all 
markers on chromosome 14 where B9 has lost the spretus allele while it is retained in 
M SCllcl.
3.3.4D Relationship between A5, B9 and MSC11 tumour
Of the 25 markers tested, DNA from the original MSC11 tumour gives the same 
result as A5 in 9 cases and the same result as B9 at 3 markers. The other 13 markers
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showed that the tumour DNA was different to both A5 and B9. This result is surprising 
because the histology of the tumour showed that it was mostly squamous. However, the 
sections of tumour used to prepare DNA and the cell lines would not necessarily have 
the same morphologies. The results can not be explained by combining the allelic ratios 
for A5 and B9, perhaps because there is too much interference from the presence of 
contaminating normal tissue DNA in the MSC 11 tumour DNA sample.
3.3.5 Summary of allelotype
The technique of allelotyping using microsatellite markers has been used to 
compile a detailed genetic analysis of clonally-related squamous and spindle cell lines. 
Alterations distinguishing the two cell types have been found and gross chromosomal 
changes have been described. While providing information describing the genetic 
differences between a pair of closely-related but phenotypically divergent cell lines, this 
allelotype has also provided clues to their lineage and hypotheses regarding their 
development from normal epithelial cells can be formed. These will also be discussed 
in more depth in Chapter 4.
3.4 Alterations in intracellular signalling pathways
3.4.1 Status of ras-related proteins
While analysis of the genetic alterations occurring during the squamous/spindle 
transition was of prime importance, it was evident that biochemical alterations were also 
involved. Genetic changes affecting H-ras have been reported in the mouse skin system 
and activation of H-ras has been shown to be an early event (Quintanilla et al., 1986; 
Bremner and Balmain, 1990). Furthermore, amplified mutant ras has been shown to be 
associated with spindle cell carcinomas (R. Crombie, PhD thesis, 1994). The mutant ras
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content of squamous tumour cells increases as they become less differentiated and this 
increase may encourage the switch to a spindle carcinoma but the complete transition 
requires the alteration of another locus. Experiments in which the ratio of mutant to 
normal ras in squamous and spindle cells was altered showed that when the mutant ras 
allele is lost from spindle cells, only their tumorigenicity and not their morphology is 
affected (R.Crombie, PhD thesis, 1994).
Ras mutations and perturbations of the signalling pathways it is involved in are 
common alterations in tumours. Ras proteins are components of receptor-mediated 
signalling pathways controlling cell proliferation and differentiation. Many of the 
components of this pathway have been identified and described in detail. They include 
raf, GAP, NF1 and K-rev. Raf, GAP and NF1 are ras effectors and as such may be 
targets for mutation in carcinogenesis. There is evidence from other studies showing 
their aberrant function in tumours (section 1.5) so their possible involvement in this 
system was investigated.
3.4.1 A Transfection with K-rev
K-rev was first isolated by its ability to revert K-ras transformed cells (Noda et al., 
1989). It was also shown to have a small effect on lung tumours (Caamano et al., 1992). 
Bearing in mind the central involvement of mutant H-ras in this system, the possibility 
that a downstream effector of cytoskeletal organisation and adhesion may be lost in 
spindle cells and the ability of K-rev to revert K-ras transformed cells, K-rev seemed an 
attractive candidate for an additional gene that is altered on the ras-related pathway. 
The available biological evidence suggested that K-rev may be an important factor in 
determining cell morphology.
Three cell lines, A5, D3 and carB were transfected with a K-rev expression vector 
but only carB produced flat revertants. These were clearly different from the parental 
carB cell line which has a fibroblast-like morphology (figure 23). Instead they 
resembled epithelial cells and formed colonies of cells in close contact with each other.
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transfectant 1 transfectant 2
Figure 23: carB cells transfected with pK rev have a flatter, 
more squamous morphology when compared with the 
parental carB spindle cells.
However, it was not possible to maintain this more squamous morphology over a long 
period of time and reverted cells rapidly lost their epithelial appearance. Some 
immunocytochemistry and immunoblotting was carried out but the revertants showed no 
expression of epithelial markers (figure 24). Although the construct seemed to be 
present in transfected cells (data not shown), elevated levels of the exogenous protein 
were not detected by immunoblotting. The reverted phenotype may have been lost by 
the time this analysis was carried out. Further investigation would be necessary to 
formally prove that the transfected cDNA is being expressed.
3.4.1 B Transfection with GAP-N
Another component of the ras signalling pathway has received a lot of attention. 
There is evidence that pl20GAP, in addition to negatively regulating ras, may also play 
a role in the downstream signalling from ras (McCormick, 1989). pl20GAP itself has 2 
effectors which may be relevant to the squamous/spindle transition: p62 and p i90. 
These are both tyrosine-phosphorylated proteins which bind to the N-terminal domain 
of GAP through its SH2 domains (Wong et al., 1992; Settleman et al., 1992). pl90 is a 
specific GAP for the rho family which, together with rac, co-ordinates cytoskeletal 
effects (Hall, 1992) therefore it may coordinate the ras and rho signalling pathways 
through its interaction with GAP.
A GAP-N construct which lacks the C-terminal ras-binding domain was 
transfected into C5N and B9 cells. It had been shown to disrupt the cytoskeleton of 
transfected fibroblasts through some interaction with p i90 (McGlade et al., 1993) so its 
effect on 2 squamous cell lines was tested. Several neo resistant lines were obtained but 
no morphological change could be seen and transfection of C5N with the truncated 
GAP-N construct had no effect on anchorage-independent growth. Expression of the 
truncated protein was not formally proven, however, and this experiment was not 
continued due to the lack of effect on morphology.
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Figure 24: Characterisation of K-rev transfectants C K l, CK4, 
CK8 and CK9. All transfectants tested show the same lack of 
expression of E-cadherin and keratin seen in the parental 
untransfected cell line, carB.
3.4.1 C Status of p120GAP and p62 proteins
On the basis of its proposed role in linking the ras signalling pathway with 
complexes that affect cell shape and attachment to substrates, the expression of 
pl20GAP was investigated in squamous and spindle cell lines. Expression of the 
pl20GAP protein was determined by immunoprecipitation (figure 25). GAP was 
expressed in all cell lines tested at similar levels and there was no difference between 
squamous and spindle lines. The same was true for p62.
p62 is a GAP-associated protein which has significant homology to an hnRNP 
protein and binds RNA (Wong et al., 1992). It is highly tyrosine-phosphorylated during 
calcium-induced keratinocyte differentiation (Filvaroff et al., 1992) and becomes 
tyrosine phosphorylated and exists in a complex with GAP in v-src transformed cells 
(Koch et al., 1992). It has therefore been proposed to be involved in cytoskeletal 
changes associated with transformation. However, no difference in expression 
associated with cell type could be seen when p62 levels were tested by Western blotting 
(figure 25).
The antibody used also showed some binding to p68, a closely-related protein, 
which also had similar expression levels in both cell types. It was concluded that 
variable expression levels of either of these components of the GAP pathway was not 
likely to be a factor determining cell morphology in the cell lines tested.
3.4.2 Detection of focal contact proteins
Many changes in gene expression occur during the squamous/spindle transition. 
Some of the most apparent changes affect the cytoskeleton. As discussed previously, 
squamous cells possess a cytoskeleton composed of cytokeratins, while spindle cells 
express vimentin. Changes in cell adhesion accompany these changes in intracellular 
architecture. The complexes which connect cytoplasmic systems with the membrane 
proteins that respond to the extracellular environment are thought to be responsible for
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the loss of cell adhesion and concomitant morphological changes during tumorigenesis; 
in general, transformed cells are more rounded and less adherent than their normal 
counterparts.
Focal adhesions are complex assemblies of many proteins, some of which have 
signalling functions and may thus have more than just a structural role. The expression 
of proteins located in focal adhesion was investigated.
3.4.2A Expression of vinculin and talin
Vinculin and talin are focal adhesion components which as yet have only been 
demonstrated to have a structural function. Their expression in squamous and spindle 
cells was studied.
Western blotting of whole cell lysates showed a correlation between expression of 
vinculin and talin and cell morphology. As shown in figure 26, all 4 entirely spindle 
cell lines tested express vinculin protein at high level. The squamous cell lines also 
express vinculin but at a much reduced level estimated to be less than half the amount. 
The same trend is seen for talin. Spindle cells express talin but it can barely be seen in 
squamous cell lysates even after a long exposure; in fact, it is completely absent from 
B9 and C5N. Cell lines which are comprised of approximately equal numbers of 
squamous and spindle cells show significant expression of both proteins similar to that 
seen for the uniformly spindle lines. The conclusion is that spindle cell lines derived 
from mouse tumours express substantial quantities of focal adhesion proteins but 
squamous cell lines derived from the same tumours have much reduced expression. 
This has relevance to studies of the cytoskeletal architecture of the two cell types.
3.4.2B Expression of FAK (focal adhesion kinase)
FAK is a major target for tyrosine kinases during various cellular events 
associated with cell adhesion and growth control. It has been proposed as a downstream
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Figure 26: S tatus of focal adhesion related proteins in squamous and 
spindle cells. All cell types express FAK ( 125kD) a t varying levels.
All cell lines express vinculin (125kD) also but there is a correlation 
between morphology and  expression level of this protein; spindle cells 
express m ore vinculin than  do squam ous cells. Only spindle cells or cell 
lines with a spindle com ponent express significant am ounts of talin 
(205kD).
transducer of integrin-mediated signals and has been implicated as a substrate for v-src 
(Guan and Shalloway, 1992) therefore any correlation between altered FAK expression 
and changes in cell morphology would be of great interest.
The total FAK expression pattern is not linked to cell morphology. When equal 
amounts of protein from whole cell lysates are loaded, all cell lines express FAK at 
varying levels (figure 26). This is interesting when the results from direct 
immunofluorescence staining of focal contacts are considered (see section 3.4.2C).
3.4.2C Detection of focal contacts by immunocytochemistry
Double immunocytochemistry using a fluorescein-linked antibody to a focal 
contact protein (vinculin, talin or FAK) and a rhodamine-linked phalloidin antibody 
reveals the localisation of focal contacts in fixed monolayers of squamous and spindle 
cell lines (figure 27). Spindle cells have extended processes projecting from the cell 
body. Focal contacts can clearly be seen where these processes presumably anchor the 
cell to its substrate (only vinculin staining is shown). This clear staining pattern is not 
so obvious in the more rounded squamous cells which lack such processes. However, 
localised expression of vinculin and FAK in focal contacts can still be seen in squamous 
cells despite expression of these proteins as shown by Western blotting (FAK 
immunofluorescence not shown).
3.4.2D Conclusions
Some differences in expression of focal contact proteins consistent with cell shape 
have therefore been established. Vinculin and talin can easily be detected in spindle 
cells by Western blotting and are clearly localised in focal contacts as seen by 
immunocytochemistry. Squamous cells express little or no talin and have a much 
reduced expression of vinculin compared to spindle cells.
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FAK is expressed by all cell types but can only be seen in focal contacts of spindle
cells.
3.5 Influence of extracellular matrix components on cell morphology
The adhesion of cells (even tumour cells) to their extracellular environment is not 
merely a passive process. During tumorigenesis, drastic alterations in intercellular and 
cell-substratum interactions take place; such alterations are particularly evident in 
tumours of epithelial origin. A characteristic of transformed cells is a reduction in 
adhesion to solid substrates which is thought to reflect the invasive and metastatic 
potential of these cells in vivo. However, the environment of tumour cells still 
influences their characteristics and behaviour.
The SN161-derived cell lines have been shown to respond to growth 
subcutaneously in nude mice by becoming more spindle. This may be a matrix or 
growth factor driven process. In an attempt to modify the phenotype of these cells in 
vitro, they were cultured on plates coated with various extracellular matrix components 
or in medium containing additional growth factors.
During routine culture it was noticed that re-seeding trypsinised cells on plates 
which had previously been used for the culture of those cells induced much more rapid 
adherence of the suspended cells and squamous populations of such cultures became 
gradually more abundant. This was especially true for all mixed morphology cell lines 
and H9 and H ll. Re-seeding squamous cells on plates previously used to grow spindle 
cell lines had no effect on their morphology and vice versa. However, seeding various 
SN161-derived cell lines on plates coated with extracellular matrix components did 
influence cell morphology.
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3.5.1 Matrigel
Matrigel is a reconstituted basement membrane derivative composed mainly of 
laminin, collagen IV, heparan sulphate proteoglycan and entactin. It has been shown to 
greatly enhance the tumorigenicity of various malignant cells (Fridman et al., 1994; 
Pretlow et al., 1991). The effect of growth on this basement membrane substitute was 
tested for the SN161 cell lines. Squamous and spindle cell lines responded differently. 
Plating the cells on thin coatings of Matrigel made the spindle cell lines, SN4, H ll and 
B8 more fibroblast-like i.e. they were more spindle-shaped and spread more (figure 28). 
There was no effect on the squamous cell lines, B9, El and E4. Thick gels made all of 
the cell lines form tight ball shapes and there was no cell spreading.
3.5.2 Collagen
Collagen has been shown to promote the dispersion of aggregates of rat bladder 
carcinoma cells (Tucker et al., 1990) so its effect was tested on various cell lines. 
Plating squamous, spindle and mixed morphology cell lines on plates coated with 
collagen I had no effect on the morphology of any cell line tested (data not shown).
3.5.3 Fibronectin
Fibronectin coated plates were also tested for their effect on cell morphology. 
They had no effect on any of the squamous cell lines, B9, E l and E4. Spindle lines, 
however, became much more fibroblast-like and spread much more than when grown on 
standard tissue culture plastic (figure 29).
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B8 + MATRIGEL
H11+MATRIGEL
E1N +MATRIGEL
Figure 28: Effect of growth on M atrigel on cell morphology.
H9 + FIBRONECTIN
H11+FIBRONECTIN
E1 + FIBRONECTIN
Figure 29: Effect of growth on fibronectin on cell morphology.
3.5.4 Conclusions
These experiments show that Matrigel and fibronectin, but not collagen I, can 
make some cell lines more fibroblast-like. Certain extracellular matrix components can 
therefore affect the morphology of metastasis-derived cell lines in vitro. This contrasts 
with the progressively more squamous phenotype that is seen when the same cell lines 
are grown on standard tissue culture plastic. The cells which become more squamous 
and attach more rapidly to their substrate may produce a matrix factor which aids 
adhesion and squamous growth but is not the same as fibronectin or any of the 
components of Matrigel. However, these matrices may have relevance to the 
squamous/spindle tendency seen when the SN161 clones are injected into the 
subcutaneous environment of nude mice.
3.6 Growth factor effects
3.6.1 Treatment with EGF and aFGF
Regulation of proliferation and differentiation in tissues is determined not only by 
interactions between cells and their extracellular matrix but also by intercellular 
communication via growth factors. These interactions are important in tumorigenesis 
especially during invasion and metastasis. Treatment of subconfluent cultures of NBT- 
II cells makes them dissociate and produces individual elongated, motile cells (Valles et 
al., 1990a). EGF has also been reported to induce subconfluent rat epithelial cultures to 
migrate (Blay and Brown, 1985). This observation has been extended to human bladder 
carcinoma cells which also disperse in response to treatment with physiological 
concentrations of EGF (Tucker, pers. comm.)
A prerequisite for carcinoma spreading and metastasis is the dissociation of the 
tumour mass, allowing some cells to escape and eventually migrate away from the
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primary site of tumour growth. Cells which have broken through the basement 
membrane are then in close contact with connective tissue rich in extracellular 
components. Local growth factors, such as EGF and aFGF, produced by endothelial 
cells may then play a crucial part in tumour cell motility by enhancing cell scattering.
The difficulty in maintaining pure clones of entirely squamous or spindle cell lines 
derived from SN161 may be due to some communication between the squamous and 
spindle cells. Most of the single cell clones seem to prefer to exist as mixed 
populations. It was proposed that the production of a soluble growth factor by one cell 
type maintains the growth of the other. This was tested by growing each cell type in 
conditioned medium. No combination had any effect on cell morphology.
The effect of growth factors known to influence cell morphology in other systems 
was tested. Treatment with EGF and aFGF which are potent inducers of the spindle 
phenotype in other cells had no effect on the morphology of SN161-derived clones.
3.6.2 Effect of TGF(3 treatment
One growth factor which has wide-ranging effects on most cell types is TGF|3. 
TGFp was first described as a soluble factor capable of transforming normal rat kidney 
cells in the presence of TGFa or EGF (Roberts et al., 1981). It is now known to have 
different effects on cell growth depending on the particular cell type and growth 
conditions and has wide-ranging list of properties (see section 1.9.1).
These include stimulation of extracellular matrix formation and promotion of 
migration. Since ECM components were shown to promote the spindle phenotype in 
some cases (sections 3.5.1 and 3.5.3), the effect of growth in TGF|3 containing medium 
was tested. The squamous cell lines, E1N, E4 and B9, all responded to incubation in 
medium containing 5-10ng/ml TGF|3 (but not to lng/ml) by changing their morphology. 
E1N and E4 rapidly lost expression of E-cadherin at cell-cell contacts as shown by 
immunocytochemistry (figure 30) and by 48 hours of treatment had adopted a more 
spindle morphology (figure 31). Although E-cadherin was beginning to be delocalised
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E1N 12hr
E1N 24hr
E4 6hr
E4 12hr
F ig u re  3 0 :  E ffec t o f  trea tm en t w ith  TCF-J3 on  E -ca d h er in  
lo c a lisa tio n  and  ex p ress io n . T h ere  is a p r o g r e ss iv e  lo ss  
o f  E -c a d h e r in  lo ca lisa tio n  a t the m em b ran e.
H11 H11 + TGFp
Figure 31: Effect of growth in TGFp-containing medium 
for 48h on morphology of E1, E4 and H11 cells.
and lost from the cell boundaries by 6h of treatment and was mostly delocalised by 18h, 
immunoblotting showed that the levels of E-cadherin protein at these time points were 
comparable with untreated cells (figure 32). This suggests that the functional protein is 
simply being redistributed at early stages. At 36h from the start of treatment, E- 
cadherin expression became reduced to about half of its original level and remained so 
until 72h.
After longer periods of TGFp treatment, E-cadherin expression was reduced 
further. Long-term treatment up to 16 days caused a substantial reduction in E-cadherin 
expression but was not completely lost even though the cells were very fibroblast-like 
and have no E-cadherin staining at the cell membranes (figure 32).
The effect of TGF|3 was completely reversible and cells returned to their usual 
morphology within 48h of the growth factor being removed. It was also noticed that 
cells which had become spindle in response to TGFp became more squamous as they 
reached confluence while still cultured in TGF(5-containing medium. This may 
influence results showing the expression levels of E-cadherin during treatment with 
TGFp. Cultures used to prepare lysates at different time points always contained a 
small proportion of squamous cells because TGFp only has an effect on cell 
morphology when the cells are subconfluent. It was impossible to maintain cultures at 
exactly the correct density throughout at all time points; there were always some 
confluent regions that had not responded. This means that the amount of E-cadherin 
being expressed during TGFp treatment is likely to be over-estimated.
Levels of keratin expression were also determined using a pan keratin antibody. 
They remained constant throughout and no change in the specific types of keratin 
expressed was seen (data not shown). Moreover, no switch to expression of vimentin 
was seen; all cells were negative throughout the time course and long-term treatment 
also failed to induce vimentin expression (data not shown).
B9 cells did not become fibroblast-like in response to TGFp. 5ng/ml had no effect 
on morphology but lOng/ml made the cells scatter and look like fried eggs! They also 
had delocalised or punctate E-cadherin staining as seen by immunofluorescence (data
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F ig u re  32: E -c a d h e r in  ex p ress io n  in E1N  cells d u r in g  tre a tm e n t  
w ith  T G F p . E -c a d h e rin  ex p ress io n  is a t  n o rm a l levels u n til 36h.
A t 42h  th e re  is a re d u c tio n  in ex p ress io n . E -c a d h e r in  p ro te in  re m a in s  
a t th is  re d u c e d  level u n til 16 days. L a n e  C is a positive co n tro l.
not shown). This higher concentration of TGF|3 was severely growth inhibitory and the 
effect on cell shape may be a consequence of this toxicity rather than a direct effect on 
morphology.
3.6.3 Conclusions
The crucial properties of TGFp with respect to invasion are connected with its 
involvement in cell-ECM interactions. TGFp can modulate interactions of cells with 
their ECM partly by inducing the synthesis of various ECM proteins. It induces the 
deposition of individual ECM components such as fibronectin and collagens (Ignotz et 
al., 1986) and modifies cell-matrix interactions via integrins (Gailit et al., 1994) (Heino 
et al., 1989) (Ignotz et al., 1989).
These properties may have relevance to the effects of TGFp treatment on 
squamous cell lines described here. It is not clear whether these responses are due to 
extracellular matrix-related effects or intracellular signalling. Further experiments 
should be able to discriminate between these two possibilities.
The effect of TGFp treatment on the morphology of squamous E1N and E4 cells 
is an exciting discovery and will be an invaluable starting point on which to base studies 
of early changes in gene expression associated with the change in morphology. It 
should now be possible to concentrate on more specific consequences of the 
squamous/spindle morphological change without interference from secondary changes.
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Chapter 4 
Discussion
4: Discussion
A large amount of evidence supports the theory that tumour progression is 
due to successive somatic mutations and an accumulation of epigenetic events that 
cooperate to progressively transform the target cells. The aim of the work 
described here has been to investigate the contribution of both genetic and 
epigenetic factors to late stages of mouse skin tumorigenesis.
One of the experimental approaches used was allelotype analysis of clonally 
related but morphologically distinct cell lines, A5, B9 and D3. A wide range of cell 
biology-based studies was also used to characterise these plus additional cell lines 
which have more plastic morphologies i.e. the SN161 single cell clones. These 
studies were designed to provide specific information relating to the control of the 
phenotypical differences existing between the cell lines tested. It was anticipated 
that such information would provide some clues to the forces influencing the 
squamous to spindle cell carcinoma transition seen in mouse skin tumorigenesis. 
The findings may also have relevance to the control of differentiation in mouse skin 
epithelia and to the epithelial-mesenchymal transition in development.
4.1 Allelotype of cell lines representative of squamous and spindle cell 
carcinomas
Large-scale chromosomal aberrations including deletions, amplifications and 
translocations are common features of mouse skin carcinogenesis (Conti et al., 
1986; Aldaz et al., 1987) but little is known about mutations specific to the late 
stage of tumorigenesis when squamous cell carcinomas progress to spindle cell 
carcinomas. This is partly due to the lack of suitable pairs of cells representative of 
each phenotype. Fortunately this laboratory has an established system ideally 
suited to the study of this process.
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Most changes may simply be consequences of the genetic instability that is 
characteristic of tumour cells. Others presumably play an important role in 
carcinogenesis since the deleted regions may contain tumour suppressor genes and 
the affected cells may therefore escape normal growth control mechanisms. Further 
genetic losses may confer malignant properties to primary tumours e.g. 
invasiveness. The purpose of the work described here was to analyse these 
changes.
Allelotype analysis has become a popular means of searching for genetic 
alterations in tumours. Part of the reason for this popularity is its ease of use but the 
main attraction is the success it has had in identifying tumour suppressor genes. 
p53 and DCC were both found by LOH studies and now most tumour types have 
had regions of LOH described (Lasko et al., 1991). This type of information is only 
of use if candidate genes can then be implicated in the development of that type of 
tumour.
In this study, cell lines characteristic of the squamous and spindle cell 
carcinoma stages have been subjected to genetic analysis by PCR amplification of 
polymorphic microsatellite markers. Previous work on these cell lines in this lab 
and by others had shown that the spindle phenotype is recessive (Stoler et al.,
1993). It was therefore proposed that the progression from a squamous cell 
carcinoma to a spindle cell carcinoma may be due to a loss of genetic information, 
possibly causing the elimination of a tumour suppressor gene. Two cell lines, A5 
and B9, were chosen for this study. As described already, (section 3.1.1) they are 
clonally-related cell lines derived from a single primary tumour. B9 is assumed to 
be characteristic of a squamous cell carcinoma since it produces squamous 
carcinomas when injected into nude mice and retains many differentiation markers 
of epithelia. A5, in contrast, produces spindle carcinomas with a short latency 
period and has a more fibroblast-like programme of differentiation.
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4.1.1 Gross genetic alterations
It seemed likely that by screening for loss of heterozygosity (LOH) it should 
be possible to isolate a small number of genetic differences distinguishing the two 
clonally-related cell types. It was hoped that a region of complete LOH in A5 
would be found to affect a gene involved in the control of epithelial differentiation.
In fact, no such losses were seen in A5; the only complete LOH was found in 
B9 on chromosome 8 at D8MIT13 where B9 has completely lost the CBA allele 
(figure 20). Since the primary tumour has both alleles at this locus and A5 and D3 
have retained the musculus allele, this result was not thought to be relevant to the 
squamous/spindle transition and further investigation of this region was not 
pursued. Nevertheless, this result suggests an interesting possibility i.e. that a non­
linear relationship exists between A5 and B9 (the musculus allele is lost in B9 but 
present in A5). B9 may have acquired this loss during progression in vivo or, more 
likely, in vitro. M SCllcl which is comprised of 75% squamous cells has both 
alleles with similar ratios to A5 and D3. There is no increase in the proportion of 
the CBA allele which might have been contributed by squamous cells. It is 
important to remember that B9 is a single cell clone from M SCllcl, therefore it 
may not be representative of all squamous cells in the tumour.
The relatively small number of complete losses of heterozygosity is 
significant in itself. Studies of human tumours show much more frequent losses. 
This may be due to the longer lifespan of tumours in patients which have been 
present for a number of years before their detection. During this time they may 
have accumulated numerous mutations. Experimentally-induced mouse tumours, in 
contrast, are usually removed before the mouse is one year old and the tumours 
used here are less than two months old. It is possible that mouse cells are less 
tolerant of LOH. LOH usually covers large regions of chromosomes and 
consequently affects large numbers of genes. Although monosomy is rare in mouse
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and human tumours and LOH is usually accompanied by reduplication, even 
homozygosity of a mutant allele is not well tolerated.
This does not mean that these cell lines derived from tumours have few 
genetic alterations when compared to control spleen DNA. Many quantitative 
imbalances have been identified, affecting nearly all chromosomes as described in 
section 3.3.1. The most interesting alterations with respect to the squamous/spindle 
transition involve chromosomes 1, 4, 5, 6, 12, 13, 16, 18 and 19. Most of these 
chromosomal aberrations involve the whole chromosome since all markers produce 
the same result. The most likely explanation of the ratios found is that some 
chromosomes have undergone non-disjunction during mitosis, causing trisomy of 
the whole chromosome.
4.1.2 Chromosome 6
Strong evidence for trisomy of chromosome 6, which has also been shown to 
be altered in primary mouse skin tumours (Kemp et al., 1993; Aldaz et al., 1989), 
has been found. Duplication of a chromosome in this way could have implications 
for the expression of genes affected by the trisomy. Trisomy may lead to increased 
expression of an important growth stimulatory gene, a property that is selected for 
during tumorigenesis. Mouse chromosome 6 has regions of homology with human 
chromosome 7 (Elliot and Moore, 1992) where the met proto-oncogene is located 
(Bottaro et al., 1991). The gene encoding the ligand for this receptor, scatter factor, 
is also located on chromosome 7 (Saccone et al., 1992) so duplication of the 
chromosome could result in increased expression of both the ligand and its receptor. 
This could have a stimulatory effect on growth. This example only applies to 
human cells since murine scatter factor is located on chromosome 5, however the 
principle could apply to many other receptors and their growth factors. It is not 
necessary for both to be on the same chromosome so there is a great deal of 
potential for over-expression of ligands and their receptors.
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Other genes on chromosome 6 could contribute to carcinogenesis by 
enhancing the growth rate of tumour cells i.e. the K-ras and raf-1 proto-oncogenes. 
Raf-1 is of particular interest since A5 and D3 are known to have amplified mutant 
H-ras while B9 has a 2:1 mutantrnormal ratio (R.Crombie, PhD thesis, 1994). The 
crucial factor in the squamous/spindle transition may be downstream from ras since 
altering the ratios of mutant and normal ras has no effect on cell morphology 
(R.Crombie, PhD thesis, 1994). Raf-1 is an effector of ras (McCormick, 1994), so 
its overexpression may aid signalling from mutant ras. This may be essential to 
mediate the effects of amplified ras. TGFa is also on chromosome 6. It has been 
shown to convert epithelial cells to a more fibroblastoid phenotype (Barrandon and 
Green, 1987).
4.1.3 Chromosome 4
There are various lines of interest in chromosome 4. It was singled out by 
Harris et al (1969) as being important in suppression of tumorigenicity. It is also 
altered in mouse skin tumours (Kemp et al., 1993). Microsatellite analysis shows 
an imbalance in favour of the musculus allele in A5 and D3 at all markers (figure 
22). The same is true for B9 at all markers between D4MIT4 and D4MIT13 but 
there is a further alteration distal to marker D4MIT13 causing a reversed imbalance 
in favour of the spretus allele which is almost certainly due to a recombination 
event between D4MIT13 and D4MIT59. M SCllcl gives the same result as B9.
This genetic difference is significant because other studies of mouse skin 
tumours have shown loss of heterozygosity on chromosome 4 in advanced 
carcinomas. Mouse chromosome 4 has some homology with human chromosome 9 
(Nadeau et al., 1992) which has been implicated in various types of cancer, but the 
changes found in A5 and B9 are distal to these regions. The region involved in the 
putative recombination is syntenic with human chromosome lp34 and lp36. It is
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not clear what relevance this has to tumour development although human 
chromosome 1 shows LOH in lung, liver and stomach cancers (Lasko et al., 1991).
4.1.4 Chromosome 11 and p53
One region where LOH may have been expected but was not found is 
chromosome 11. This is commonly altered in tumours, presumably because it
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harbours the p53 gene. In fact, p53 j mutation is often seen in LOH studies in Li 
Fraumeni patients (reviewed in Lane and Benchimol, 1990). Allelotypes of mouse 
skin tumours have identified LOH on chromosome 11 but no difference between 
the squamous and spindle cell lines and control DNA was seen here. This may be 
due to the cells already possessing two mutant p53 alleles (Bums et al., 1991) 
therefore no further inactivation of the gene is required and there is no selective 
advantage of having LOH on chromosome 11.
The mutation of p53 is more likely to have an important effect at earlier 
stages of tumorigenesis before the divergence of the squamous and spindle cell 
carcinoma phenotypes since both A5 and B9 have the same 3 p53 point mutations. 
p53 does seem to have a role in tumour progression and studies using knockout 
mice have demonstrated a function for p53 specifically at the benign-malignant 
transition in mouse skin tumours (Kemp et al., 1993); p53 LOH was seen only in 
carcinomas, not papillomas. The stage under investigation here is even more 
advanced and represents the progression to a more invasive and metastatic 
phenotype when p53 mutations are not causal factors.
Further support for this hypothesis comes from the study of SN161 cells. 
They were derived from a metastasis and have an 8 base pair deletion in p53 (Bums 
et al., 1991). The primary tumour, SN158, has the same deletion, therefore p53 
mutation in this case also preceded metastasis and invasion.
The role of mutant p53 in this model system is more likely to be related to its 
function as "guardian of the genome". p53 null cells become aneuploid quickly
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once in culture and most cells which get gene amplifications lack p53 (Harvey et 
al., 1993). Therefore, a loss of p53 function may go some way to explaining the 
number of chromosomal abnormalities seen in both A5 and B9 compared to control 
normal spleen DNA.
In order to acquire the number of mutations required for carcinoma 
development, the mutation rate of the tumour cells must have been increased 
beyond that of normal cells i.e. the tumorigenic cells must have a "mutator 
phenotype" (Loeb, 1991; Nowell, 1976). The background mutation rate of normal 
cells even in the mouse (which has a lower capacity for DNA repair when compared 
to human cells) can account for only 2 or 3 mutations in each tumour and not the 
much larger number of mutations identified in tumours. However, if an early 
mutation causes the elimination of a DNA repair function then this mutation rate 
could increase dramatically.
Creating double minutes would be one way of producing the large 
amplifications seen. They have already been shown to harbour the amplified 
mutant ras gene in A5 cells (N. Keith, unpub.).
4.1.5 Other genetic changes
Putative trisomies and other genetic alterations involving chromosomes 1, 5, 
12,13,16, 18, and 19 may also have carcinogenesis-promoting results.
As described already, the allelotype of the MSC cell lines shows a large 
number of genetic alterations, many of which are likely to be whole chromosome 
trisomies. Duplications of various chromosomes are consistent with the karyotypes 
of A5 and B9. Both cell lines appear to be tetraploid (data not shown) so there is 
the potential for more than one copy of each chromosome to be represented as 
indicated by the total chromosome number.
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There are also some more localised changes distinguishing the squamous and 
spindle cell lines. It is not possible to determine whether these involve a loss or 
gain of function since the nature of the PCR technique allows only the relative 
amounts of each allele to be determined. The imbalances could therefore be support 
for either oncogene or TS gene involvement in the process of tumour development. 
Changes in specific genes which may influence the squamous-spindle transition 
have not yet been identified.
4.1.6 Clues to the relationship between A5, B9 and MSC11T
Since the original MSC 11 tumour was mainly squamous and the MSC 11 cell 
line derived from it was mainly comprised of squamous cells with a minority of 
approximately 25% spindle cells, it was thought that microsatellite results for 
MSC 11 tumour DNA would reflect these proportions. Surprisingly, this was not 
the case; of the 25 markers tested, only 3 showed the same result as B9 and only 7 
were the same as A5 (data not shown). The remainder differed from both A5 and 
B9. Combining the ratios for squamous and spindle cells did not improve the 
relationship. It may be that the section of tumour used for histology had different 
proportions of squamous and spindle cells compared to the piece used for DNA 
preparation or that the piece used for DNA preparation had a significant proportion 
of contaminating normal cells. In addition, the major clone that represented the 
tumour in vivo may not have been the one that adapted best to culture conditions.
Some interesting conclusions regarding the relationships between the various 
cell lines and tumour cells can be deduced from the microsatellite analysis. Initially 
it was thought that B9 would be more similar genetically to the primary tumour 
than A5 would. It was predicted that A5 would have acquired genetic alterations 
not seen in B9 and that there would be a linear relationship between the primary 
tumour, B9 and A5. This has proved not to be the case. It is more likely that A5 
and B9 both derived from a common intermediate on the tumorigenesis pathway
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and were the result of two separate lines diverging from this predecessor which 
presumably would have the three p53 mutations and one ras mutation. This would 
explain how A5 could retain genetic information that is lost in B9. Therefore A5 
and B9 are more distantly related genetically than was first thought and the 
differences between them are too numerous to allow any conclusions to be drawn 
from this study regarding the cause of the different phenotypes.
It is interesting that only a relatively small number of changes appear to take 
place in vitro. There are few differences between A5 and D3 j B9 and MSC 11 cl 
are also very alike genetically. This suggests that most of the alterations found are 
relevant to the development of the tumour and are not in vitro culture artifacts.
4.2 Induction of the sauamous-spindle transition in  v iv o  and in  v itr o
It was hoped that the morphology of A5 or B9 could be altered 
experimentally in order to provide a model system where a limited number of 
variables could be changed to switch the cell phenotype in either direction as 
required. The close relationship of the two cell lines made this an attractive 
proposition since the number of differences between them should be relatively 
small and, furthermore, they should be directly related to the change of phenotype. 
However, no attempts to alter the morphologies of A5 and B9 have been successful. 
These have included exposure to ionising radiation up to 5Gy (data not shown), 
treatment with growth factors and conditioned medium and growth on various 
matrix components. In contrast, the SN161-derived cell lines have responded to 
several types of treatment and it has been possible to alter either morphology. 
Other unrelated cell lines were included in some assays. One of these was CarB.
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4.2.1 Reversion of spindle phenotype by transfection with K-rev
One method was successful in reverting the spindle phenotype of a cell line 
unrelated to A5 and B9. CarB cells which are normally very fibroblast-like were 
switched to a more epithelial morphology by transfection with K-rev (figure 23). 
Although A5 and D3 were also transfected, they did not change morphology. K-rev 
is known to increase the degree of differentiation of lung tumour cells (Caamano et 
al., 1992) and was originally identified as a result of its ability to revert 3T3 cells 
(Kitayama et al., 1989). It has been proposed to block the proliferation function of 
ras, therefore promoting its differentiating function. If this is true, the ras status of 
transfected cells will be important in deciding whether K-rev can cause any 
reversion or not. This may explain why A5 and D3 did not respond; they both have 
amplified mutant ras carried on double minutes while carB has homozygous mutant 
ras with no amplification i.e there may be a dosage effect.
Unfortunately the reverted phenotype was not stable in culture. Transfected 
cells which had previously been epithelial rapidly lost this morphology after only a 
few passages. It seems that the pressure to maintain the spindle phenotype is too 
great in these cells and they quickly lose any squamous features. 
Immunocytochemistry and immunoblotting analysis failed to show the expression 
of epithelial markers such as keratins and E-cadherin (figure 24) so it can be 
concluded that the change in morphology seen here is only a partial reversion. 
Expression of the K-rev protein was not formally proven although the presence of 
the transfected construct was confirmed by Southern blotting (data not shown).
4.2.2 Plasticity of SN161 clones
Compared with the fixed state of the MSC lines which have had no known 
phenotypic alterations since the time when they were single cell cloned, the SN161 
cell lines show much more plasticity. They were isolated from a lymph node
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metastasis derived from a skin tumour in a 129/NIH hybrid mouse that had been 
treated with chemical carcinogens. There are 11 single cell clones derived from the 
original SN161cl. Within this group there are representatives of squamous and 
spindle cell lines plus other intermediate morphologies. These cell lines have 
proved to be much less stable with respect to morphology than the MSC 11 cell lines 
and it has been possible to alter their phenotypes by a number of methods.
4.2.3 Manipulation of cell phenotype by in  v iv o  and in  v itr o  factors
The first indication that the SN161 cell line could alter its morphology came 
from tumours induced by injection of this cell line into nude mice. It was noticed 
that although SN161 is 75% squamous, it produced spindle tumours in vivo. It was 
later shown that squamous cells derived from the original tumour-producing cell 
line could be recovered from a tumour explant in vitro. The identity of these cells 
as 129/NIH hybrids was confirmed by PCR and the possibility of recruitment of 
host cells was ruled out (section 3.2.4). It could therefore be concluded that the 
cells were capable of existing as squamous populations in vitro but were converted 
to spindle cells in vivo and that this process was reversible. The same was true for 
all of the subclones; every cell line produced spindle tumours in nude mice 
regardless of its morphology in vitro. It is not clear if the important factor causing 
the switch is a component of the culture conditions or is present in the subcutaneous 
environment of the mouse skin.
Other studies using mouse models have produced similar results indicating 
that the squamous phenotype of carcinomas is unstable. It was shown that the 
expression of several keratins is suppressed when transformed cells are injected into 
nude mice and they are re-expressed when the nude mice-derived tumours are re­
established in tissue culture. This suggests that control of keratin expression 
depends not only on the degree of transformation of the cells themselves but also on 
host-derived factors (Banks-Schlegel and Rhim, 1986). Similar findings were
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obtained in experiments where the expression of E-cadherin was being monitored 
(Mareel et al., 1991).
The result with the SN161 cell lines obviously merits further investigation. It 
is possible that extracellular factors such as matrix components or growth factors 
are playing an important part in this process. Some experiments were carried out to 
test this hypothesis.
4.2.4 Importance of tumour cell environment
It is clear that the environment of the SN161-derived cells is able to determine 
their phenotype. Tumour-extracellular matrix interactions are also known to be 
influential in growth and development and are not merely passive. Carcinoma cells, 
like normal cells, are surrounded by cellular connective tissue composed of 
fibroblasts, endothelium and other cells in a dense network of proteins which 
provides them all with a 3D structural framework and influences their behaviour.
It is significant that the SN161cl was derived from a lymph node metastasis, 
unlike the MSC cell lines which were derived from a primary squamous cell 
carcinoma. The plasticity of the SN161 clones may be a direct result of the type of 
tumour they were isolated from.
The metastatic process is regulated by a balance between adhesive forces 
linking cells together and cell-substratum interactions. Human tumour metastases 
are usually squamous but they are unlikely to have metastasised in this morphology. 
They may have had a degree of plasticity which has allowed them to become 
spindle transiently, therefore adopting more motile characteristics that allowed them 
to move from one position to another. This possibility has been addressed 
experimentally (Boyer et al., 1989) and it seems plausible although the rat bladder 
cells used in this work are not an ideal model. Results with the SN161 clones 
provide further evidence to support this hypothesis.
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Metastases are rare in mice but the same principles apply as to human 
tumours. The SN161 tumour may have arisen as a result of cells from the original 
skin carcinoma (SN158) becoming motile transiently. These cells may have been 
spindle until they reached the lymph node where they settled and, due to local 
environmental factors, regained their squamous morphology. Cells from the 
resulting SN161 tumour may have retained this capacity to respond to certain 
extracellular factors. Therefore, although the MSC 11 and SN158 tumours were 
both induced by chemical carcinogen treatment, there are clear differences in 
behaviour. SN161 cells may represent intermediate cell types between the extremes 
of A5 and B9 since they can be induced to become more spindle or squamous.
Various factors could be responsible for the induction of a fibroblast-like 
morphology in vivo. These include components of the extracellular matrix such as 
structural proteins and growth factors. The effects of some of these were 
investigated.
4.2.5 ECM proteins influence cell morphology
It is generally assumed that epithelial cells break through the basement 
membrane and invade the underlying mesenchymal stroma which is relatively 
passive in the metastasis process. However, mesenchymal cells might actively 
suppress carcinomas in adjacent epithelia and the loss of such active suppression 
might contribute to carcinogenesis. Alternatively, there may be ECM proteins 
present which aid the acquisition of a motile, fibroblast-like phenotype by the 
invading tumour cells. Matrigel (a reconstituted basement membrane derivative 
composed mainly of laminin and collagen) greatly enhances the tumorigenicity of 
various malignant cells (Fridman et al., 1994; Pretlow et al., 1991). Tumour cells 
premixed with Matrigel then injected into nude mice consistently produced tumours 
which grew faster and became much larger than tumours induced by the same cells
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injected without Matrigel. Some interaction of premalignant cells with ECM 
components can therefore contribute to the process of tumorigenesis.
The effect of plating the various SN161 single cell clones on different matrix 
components was tested. Collagen I had no effect on morphology but both Matrigel 
and fibronectin made the spindle cell lines even more fibroblast-like (figures 28 and 
29). Squamous cell lines were unaffected.
The response to Matrigel and fibronectin may be due to the presence of 
different matrix receptors on the surface of the spindle cells or due to their ability to 
activate the appropriate receptors. Signalling through such receptors e.g. the a5(31 
integrin which binds to fibronectin may trigger a growth response that involves a 
change in cell morphology. The expression pattern of integrins has not been 
determined for these cell lines but this would be recommended since they are so 
important in responding to the extracellular environment (section 4.2.8).
It was thought that perhaps the squamous and spindle cell lines produced 
different matrix components which affected their morphology; some spindle cell 
lines acquired isolated squamous colonies after long periods in culture and 
suspended cells settled much more quickly on dishes which they had previously 
been growing in compared with fresh dishes. Plating either squamous or spindle 
cells on plates which had previously been used to grow the other type of cell line 
had no effect on morphology, so the difference does not seem to be due to the 
secretion of alternative matrix proteins by the cells.
4.2.6 Growth factors influence cell morphology
The effect of treating cells with aFGF, EGF or TGF|3 was tested. aFGF and 
EGF had no obvious effect on phenotype, but TGF(3 treatment produced a dramatic 
response.
TGF|3 regulates the proliferation and differentiation of normal cells. Both of 
these functions may be important in tumour formation. TGF(3 has a dual role in
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carcinogenesis, inhibiting papilloma development but enhancing progression once 
neoplastic transformation has occurred and the growth inhibitory response to TGF(3 
has been lost (W.Cui, unpublished). Overexpression of TGF(31 in carcinoma cells 
enhances tumorigenesis and metastatic spread (Welch et al., 1990). This effect may 
be related to the ability of TGFp to influence mesenchymal-epithelial interactions.
Treatment of E1N and E4 (both squamous clones) induced an epithelial- 
mesenchymal transition in 24-48h. At first E-cadherin became delocalised and its 
expression level reduced, then the cells became more spindle. High doses of TGFp 
(lOng/ml) were required to produce this response but it was obvious and fairly 
rapid. Although the mechanism by which this occurs has not been identified, the 
treated and untreated cells will be invaluable for further studies of changes 
accompanying the squamous-spindle transition and immediate consequences of the 
change in morphology.
Other functions of TGFp, besides growth inhibition, include modulation of 
cell-ECM interactions e.g. by inducing the synthesis of various ECM components 
such as collagen and fibronectin (Ignotz et al., 1987). The culture of cells on 
collagen I coated plates did not have any effect on morphology in this study but 
growth on fibronectin and Matrigel which contains laminin and collagen IV made 
the spindle cells spread more and become more fibroblastic. The morphology 
induced by growth on these substrates was similar to that induced by treatment of 
squamous cells with TGFp although these squamous lines showed no response to 
growth on matrix components. The two effects may be unrelated but it is tempting 
to assume a link between them.
Perhaps a more intriguing possibility is the induction of scatter factor 
expression by TGFp. TGFp can strongly upregulate the steady-state levels of c-met 
mRNA, the scatter factor receptor, in human carcinoma cell lines (Moghul et al.,
1994) and the expression pattern of c-met is greatly upregulated in tumour tissues 
and several carcinoma lines (Prat et al., 1991). Scatter factor has several well- 
described effects on cell morphology and motility (see section 1.8.2), all of which
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are relevant to the acquisition of a more spindle, invasive phenotype during late 
stages of tumour progression. This may be the outcome of treatment of squamous 
carcinoma-derived cells with TGFp.
Another possibility is that the high doses of TGFp used to induce a change in 
morphology are not acting solely through the TGFp receptor II; TGFp may also be 
binding to the activin receptor which is closely related. Activin is a key signalling 
molecule in the induction of dorsal mesoderm (Hoffmann, 1991). It reduces the 
adhesive strength of cadherin-mediated adhesion in blastomeres, allowing cells to 
exchange neighbours during the complex movements of gastrulation in Xenopus. 
This process is reminiscent of the delocalisation of E-cadherin followed by cell 
scattering and gain of spindle phenotype that is seen in response to TGFp. It will 
therefore be important to determine the effect of treating the same cells with activin.
4.2.7 Growth factors that affect cell morphology work via tyrosine 
kinases
Both E1N and E4 responded to TGFp within 12h of the start of treatment. E- 
cadherin localisation was beginning to be altered at 6h and it had become fully 
delocalised by 24h. This was long before a change in the expression of E-cadherin 
protein could be seen; a change in protein levels was first detected at 36h. The 
implication of this timing is that existing E-cadherin complexes are being modified 
in response to the extracellular stimulus.
E-cadherin is a key component in the squamous-spindle transition. The E- 
cadherin junctional complex that includes catenins is broken down as a result of 
tyrosine phosphorylation. This is a common feature of the acquisition of a spindle 
phenotype and tyrosine phosphorylations are common responses to growth factor 
signalling. Indeed, tyrosine phosphorylation of E-cadherin or catenins is often seen 
during transformation when cells become more spindle (Behrens et al., 1993; 
Hamaguchi et al., 1993).
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It is also possible for cells which are not expressing E-cadherin protein to 
regain expression of the correctly positioned and functional protein. This was 
observed in the spindle cell lines, H9 and H ll. After some time in culture they 
gained a number of small squamous regions which were positive for E-cadherin 
expression as shown by immunocytochemistry (figure 13). Surrounding spindle 
cells remained negative. A similar effect was seen in cells which were being treated 
with TGFp. Where the culture was subconfluent the cells were spindle and E- 
cadherin was delocalised; as they became confluent and made contact with their 
neighbours, correct E-cadherin expression reappeared.
In both cases close cell-cell contact reactivates the E-cadherin complex. It is 
known that the E-cadherin promoter is active in H9 and H ll even when there is no 
E-cadherin protein production (G. Portella, unpublished) so it seems that some post- 
transcriptional mechanism is capable of regulating the junctional complex either by 
acting on E-cadherin itself or another component such as the catenins. This 
phenomenon is currently being investigated.
4.2.8 ECM protein and growth factor effects can be mediated by 
integrins
Changes in integrin expression can have profound effects on the neoplastic 
phenotype since they are important mediators of cell-cell and cell-ECM interactions 
and changes in these interactions are characteristic of malignancy. Such changes 
are particularly important for invasion and metastasis (Dedhar, 1990; Plantefaber 
and Hynes, 1989; Schwartz and Ingber, 1994).
The expression of a particular integrin complex is tissue and cell type 
specific. a6|34 is the predominant integrin of squamous cell carcinomas and in skin 
and redistribution of a6(34 to the suprabasal compartment is a marker of high risk 
for malignant progression (Tennenbaum et al., 1993). Therefore, qualitative and 
quantitative changes in cell surface matrix receptors are linked to the malignant
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conversion and may contribute to altered interactions of carcinoma cells with their 
surrounding normal cells and stroma. These epigenetic changes in benign tumour 
cells may encourage the development of characteristics generally attributed to the 
malignant phenotype.
4.3 Markers distinguishing squamous and spindle cells
The work presented here illustrates some phenotypic differences between 
squamous and spindle cells and between cells whose morphologies are fixed and 
those which can change morphology to some extent. The most obvious differences 
are the alternative intermediate filaments possessed by squamous and spindle cells 
and the presence or lack of E-cadherin. Other markers which are likely to be 
consequences rather than determinants of the phenotype are focal adhesion proteins 
such as vinculin and talin. These were expressed at high levels in spindle cells but 
were only just detectable or absent in squamous cells. Total FAK expression 
showed no consistent difference between the two cell types but the difference in 
this case could be more subtle e.g. contrasting degrees of phosphorylation. This 
possibility was not investigated. The presence or absence of focal contact proteins 
is probably a result of signalling from an upstream control of morphology which 
co-ordinates these and other mutually exclusive markers such as keratin and 
vimentin proteins.
More likely candidates for determination of cell morphology were GAP and 
p62 or p68 since these are closer to the control centres of the cell in terms of 
signalling. None of these showed any difference between squamous and spindle 
cells.
The alternative expression of those markers which did have some link with 
morphology was consistent among the fixed and plastic morphology cell lines. It 
may be that the switch from squamous to spindle in SN161-derived cells is 
influenced by epigenetic factors while it has become fixed by genetic changes in the
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MSC 11-derived cells. Both factors are known to be relevant to the carcinogenesis 
process. SN161 may have arisen from an "earlier" target cell which still has the 
capacity to undergo the epithelial-mesenchymal transition.
4.4 Genetic and epigenetic events in carcinogenesis
Epigenetic events and mutations are not mutually exclusive; together they 
account for all the heterogeneity seen between and within tumours. Tumour 
evolution requires a selective mechanism using genetic and epigenetic forces that 
combine to create a carcinogenic phenotype. Combinations of different forces are 
involved at each stage of tumorigenesis.
It is well documented that initiation results from genetic events. The 
mechanism of promotion is likely to be epigenetic since only 2 or 3 genetic changes 
in normal keratinocytes are sufficient to produce papillomas (Roop et al., 1986; 
Bailleul et al., 1990) and promoting agents aren't always mutagens. The cause of 
progression may also be due to epigenetic events, although genetic events are 
undoubtedly required for the development of true spindle cell carcinomas.
The reversible phenotypic modifications seen here may occur by similar 
mechanisms to those occurring in tumour progression. Cells switching between 
squamous and spindle morphologies, whether in vitro or in vivo, may acquire 
changes in expression of the same set of genes. However, the changes in tumours 
are probably fixed by genetic alterations. The hyperproliferative phenotype of 
papillomas could contribute to the spontaneous accumulation of such chromosomal 
changes associated with progression in skin carcinogenesis. This could then create 
the correct conditions for the evolution of cells which become spindle cell 
carcinomas through further genetic alterations or in response to epigenetic factors.
Loss of adhesion and disorganisation of cell and tissue architecture are not 
immediate consequences of growth deregulation due to oncogene activation or 
tumour suppressor loss; rapidly growing but well-differentiated tumours are
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common. Genetic changes that lead to permanent activation of growth regulatory 
pathways occur first and allow subsequent mutations in genes that are involved in 
cell-ECM adhesion. Once tumour growth becomes independent of adhesion, 
selection for a range of different phenotypes becomes possible. Without a 
preceding loss of anchorage dependence, the cells without a normal adhesion 
system and cytoskeleton would not be viable. Once cells have become ECM 
independent, the cell and tissue structure can become more disorganised.
Cadherins are important in maintaining tissue organisation and have been 
classed as tumour suppressors since they show decreased expression or functional 
inactivation in tumours and their overexpression leads to reduced tumorigenicity 
(reviewed in Takeichi, 1993). They are important in cell-cell adhesion and connect 
to the cytoskeleton but there is no evidence as yet that cadherins directly regulate 
intracellular growth control pathways or that cell-cell adhesion contributes to cell 
growth in a manner similar to cell-ECM adhesion. Despite this they do have an 
anti-tumorigenic role, if only as a mechanical restraint on motility.
Epigenetic and genetic factors may affect the same pathways in different 
ways. Growth independent of both anchorage and soluble mitogens can be induced 
by many transforming agents e.g. src can activate the integrin-mediated pathway 
independent of adhesion to substrates that normally causes activation (Guan and 
Shalloway, 1992). Oncogenes and tumour suppressors may irreversibly activate 
pathways controlled by integrins as well as by growth factors. These alterations can 
make cells independent of particular growth factors and may constitutively activate 
integrin pathways. Clearly this would affect both growth and adhesion-related 
properties. Thus epigenetic and genetic factors can promote tumorigenesis by 
acting on the same pathways; the difference is that genetic alterations are fixed 
while epigenetic alterations are usually reversible.
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4.5 Parallels betw een neoplasia and developm ent
The conversion between epithelial and mesenchymal morphologies in 
neoplasia is similar to the epithelial-mesenchymal transition seen in embryonic 
development and can be mimicked in vitro in appropriate culture conditions (see 
section 1.8). Tissue remodelling, whether in morphogenesis, wound repair or 
pathogenic situations such as invasion and metastasis of tumour cells, requires the 
epithelial cells to acquire a degree of motility that is not normally a property of 
these cells. There are two ways in which epithelial cells can move; they can remain 
linked together and move as an epithelial sheet as in gastrulation and wound healing 
or they can dissociate and migrate as individual cells. During embryogenesis, the 
gain of motility is associated with a dramatic change in the programme of cell 
differentiation. Migrating cells acquire a mesenchymal phenotype exhibited by a 
change in their cytoskeletal organisation (they no longer express keratins and 
express vimentin instead) and decreased cell-cell adhesion. This conversion is 
reversible.
Analogous to the situation in development, tumour cells can also be plastic. 
Indeed, the squamous/spindle transition that occurs late in carcinogenesis may be a 
recapitulation of the epithelial-mesenchymal transition which takes place during 
development. Epithelial cells lose their characteristic markers e.g. keratins and 
adopt a more fibroblast-like phenotype which involves expressing vimentin and 
becoming more spindle shaped. Their reduced cell-cell and cell-substrate adhesion 
contributes to increased potential for motility.
Developmental processes can be influenced by a number of parameters e.g. 
ECM components and cell adhesion molecules but a key role is played by soluble 
growth factors. There are developmental abnormalities associated with alterations 
in growth factor or growth factor receptor function. Moreover, some growth factors 
and their receptors have oncogenic potential.
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One such growth factor is TGFp. It has a role in epithelial morphogenesis 
(including the epithelial-mesesnchymal transition) (Heine et al., 1987) and can also 
have various effects during carcinogenesis (section 1.9.1). The results presented 
here indicate that TGFp treatment of squamous cells can induce a phenotype that 
resembles spindle cells. Characterisation of these cells has shown that their 
similarities to spindle tumour cells are striking. As the cells scatter and become 
more fibroblast-like, E-cadherin expression becomes delocalised. It would be 
interesting to know if this effect (produced by treatment with a high concentration 
of TGFp) is acting through the activin receptor rather than a TGFp receptor since 
the same alterations to E-cadherin are seen during gastrulation in Xenopus in 
response to activin signalling (Ueno et al., 1990).
4.6 Similarities between neoplasia and mitosis
Studies such as this also provoke suggestions that tumour cells may be 
caricatures of mitotic cells since links between tumour cell phenotypes and normal 
cellular processes can be found. There are many similarities between alterations 
that take place during transformation and mitosis. The same pathways may be 
involved in both cases since mitotic cells, like tumour cells, have reduced adhesion 
to their substrate and their cytoskeleton is disassembled. It is possible that tumour 
cells copy mitotic cells and some of the pathways involved are the same. 
Observations such as this suggest that tumour cells can be likened to cells 
permanently in mitosis i.e. altered cell cycle control may be involved. Therefore, 
evidence is now growing to suggest that tumorigenesis, development and mitosis 
depend on different ways of utilising the same cellular processes. The precise 
differences in the ways that these are regulated are the key unanswered questions.
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4.7 Suitability of the mouse skin model system
Many discoveries from studies of mouse skin have been landmarks in cancer 
research and they have provided many insights into the processes of tumorigenesis. 
Evidence has been obtained for the multistep nature of skin carcinogenesis in mice 
and distinct stages have been described (section 1.4.2). Other findings have 
included evidence for the clonal origin of benign and malignant tumours, the 
requirement for multiple genetic changes in malignant conversion and the binding 
of carcinogens to DNA (rev in Slaga, 1984).
Experimental skin carcinogenesis is the favoured model for understanding the 
pathogenesis of squamous cell carcinomas. As mentioned previously, distinct 
stages have been identified and the process of tumour development can be separated 
into the various steps of the pathway shown in figure 4. Recent advances have 
linked specific genetic and biological alterations with each of these stages. The 
work described here has contributed to the data, especially to the final stage of 
progression i.e. the transition from a squamous to a spindle cell carcinoma.
Permanent conversion to a spindle cell carcinoma, which involves a complete 
change in cell phenotype, is not seen in all carcinomas. In fact, it is less common in 
human tumorigenesis than in the mouse model system. However, reversible 
conversion may be very common and therefore is still of great interest in 
understanding the processes that become disrupted in tumour development and is of 
central relevance to the mechanisms of invasion and metastasis. Study of these 
processes will not only provide information about the behaviour of tumour cells; it 
will also give an insight into the control of epithelial differentiation and 
development.
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